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Abstract: Almost every cell of the human body is constantly exposed to DNA damaging agents of
exogenous and endogenous origin, which can cause various lesions in the genome. These DNA damages can
have mutagenic potential and lead to genomic instability that is one of the major drivers of carcinogenesis.
To deal with DNA alterations, cells have developed highly specialized DNA repair pathways. Two distinct
mechanisms, termed non-homologous end joining (NHEJ) and homologous recombination (HR), deal
with repair of DNA double- strand breaks (DSBs), the most dangerous form of DNA damages. HR is
an accurate repair mechanism, but it is restricted to S and G2 phases of the cell cycle. On the other
hand, NHEJ can take place throughout the cell cycle and is error-prone. HR reaction relies on an
initial 5’ to 3’ DNA end resection step generating 3’ ssDNA overhangs. In yeast, the Exonuclease 1 and
the helicase/nuclease Dna2 in conjunction with the RecQ-type helicase Sgs1 constitute two independent
pathways for long-range DNA-end resection. In human cells, there are five RecQ homologs known, namely
RECQL1, BLM, WRN, RECQL4 and RECQL5. It has already been demonstrated that human BLM can
mediate DNA-end resection in conjunction with DNA2. However, data obtained from a study in Xenopus
egg extracts identified WRN as the major helicase that works in complex with DNA2 to catalyse DNA-
end resection. Therefore, we wanted to investigate whether WRN can mediate DNA-end resection in
conjunction with DNA2 in human cells. Within this thesis work it is demonstrated that indeed WRN
can promote DNA2-mediated DNA end processing and that this process is dependent on the presence of
RPA and ATP. In addition, this reaction occurs in 5’ to 3’ direction generating the anticipated 3’ ssDNA
overhang required for HR repair. Further, we provide evidence for the physical interaction of WRN and
DNA2 in vitro and in vivo. Moreover, we found that WRN and BLM stimulate extensive DNA end
resection by DNA2 in vivo. Finally, we show that BLM mediates DNA-end resection as part of the BLM-
TOPOIII￿-RMI1-RMI2 (BTRR) complex. Taken together our data provide evidence that in human cells,
DNA2 resects broken DNA ends in conjunction with either WRN or BTRR complex. The 3’ ssDNA tail
generated by DNA-end resection is subsequently coated with RPA and does not only serve as a substrate
for the loading of RAD51 recombinase, but also provides a platform for the activation of ATR kinase that
is recruited to RPA-coated ssDNA trough its interacting protein ATRIP. Activated ATR phosphorylates
CHK1 thereby inducing the DNA damage checkpoint that leads to a cell cycle stop. Although previous
studies show that MutS￿, a heterodimeric mismatch repair protein composed of MSH2 and MSH3, is
involved in the HR process, its exact function is unclear. In this thesis work, it is demonstrated that MutS￿
serves as a mediator in ATR activation upon DNA DSB induction in human cells. We provide evidence
that MSH2, MSH3 and ATR/ATRIP form a complex in cells. In addition, we show that siRNA-mediated
depletion of MSH2 or MSH3 impairs the phosphorylation of ATR targets and the formation of ATRIP
foci in response to replication- associated DNA DSBs. Further, mutations in the mismatch-binding
domain of MSH3 diminished the binding of MutS￿ to persistent hairpin loops in RPA-coated ssDNA and
compromised ATR activation in vivo. Thus, our results demonstrate that MutS￿ binds to hairpin loop
structures persisting in RPA-coated ssDNA at sites of DNA damage and mediates recruitment of the ATR-
ATRIP complex for its activation. HR has the potential to generate chromosomal rearrangements trough
crossover formation. While crossovers are required in meiotic cells for proper chromosome segregation, in
mitotic cells, HR predominantly proceeds via the synthesis-dependent strand annealing (SDSA) pathway
that always leads to non-crossover products. This implies that mitotic cells possess a stringent control
system for HR subpathway selection. However the underlying molecular mechanism is not well defined.
Here, we present evidence that siRNA- mediated knockdown of RECQ5 impairs DNA DSB repair by
SDSA in human cells. Further, we provide in vivo and in vitro data demonstrating that RECQ5 helicase
counteracts the inhibitory effect of RAD51 on RAD52-mediated ssDNA annealing, a key step of SDSA.
Finally, we show that RECQ5 suppresses sister chromatid exchanges in human cells in a complementary
manner with the BTRR complex that mediates the dissolution of recombination intermediates to prevent
crossovers. These results suggest that RECQ5 acts during the post-synaptic phase of SDSA to prevent
formation of aberrant RAD51 filaments on the extended invading strand, thus limiting its channeling
into potentially hazardous crossover pathway. Taken together, the results of this thesis work identify new
key players and their exact working mechanism in the cellular response to DNA DSBs and thus provide
potential new therapeutic targets for cancer therapy.
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1. Zusammenfassung	
	
Fast	 jede	Zelle	des	menschlichen	Körpers	 ist	konstant	DNS	schädigenden	Stoffen	exogenen	
oder	endogenen	Ursprungs	ausgesetzt,	welche	zu	 	verschiedensten	Genomschäden	 führen	
können.	 Diese	 DNS-Schäden	 sind	 potentiell	 mutagen	 und	 können	 zu	 einem	 instabilen	
Genom	führen,	einem	der	treibenden	Faktoren	für	die	Krebsentwicklung.	Um	solchen	DNS-
Veränderungen	 entgegenzuwirken,	 haben	 Zellen	 hochspezialisierte	 DNS-Reparatursysteme	
entwickelt.	 Zwei	 unterschiedliche	Mechanismen,	 bekannt	 als	 nicht-homologes	 End-Joining	
(NHEJ)	 und	 homologe	 Rekombination	 (HR),	 sind	 für	 die	 Reparatur	 von	 DNS-
Doppelstrangbrüchen	 zuständig,	 der	 gefährlichsten	 Form	 von	DNS-Schäden.	Die	HR	 ist	 ein	
sehr	genauer	Reparaturmechanismus,	 allerdings	 ist	 sie	beschränkt	auf	die	 S	und	G2-Phase	
des	 Zellzyklus.	 Dem	 gegenüber	 steht	 das	NHEJ,	welches	während	 des	 gesamten	 Zellzyklus	
stattfinden	kann,	jedoch	fehleranfällig	ist.	Um	sie	zu	initiieren,	benötigt	die	HR-Reaktion	eine	
DNS-End-Resektion,	 die	 in	 5’	 zu	 3’-Richtung	 verläuft	 und	 einen	 3’-Einzelstrang-DNS-
Überhang	generiert.	In	Hefezellen	bilden	die	Exonuklease	1	und	die	Helikase/Nuklease	Dna2	
zusammen	mit	der	RecQ-Typ	Helikase	Sgs1	zwei	verschiedene	Proteinmaschinerien,	die	 zu	
einer	extensiven	DNS-End-Resektion	führen	können.	In	menschlichen	Zellen	sind	jedoch	fünf	
RecQ	Homologe	bekannt,	nämlich	RECQL1,	BLM,	WRN,	RECQL4	und	RECQL5.	Es	wurde	schon	
bewiesen,	 dass	 das	menschliche	BLM	Protein	 im	Zusammenspiel	mit	DNA2	eine	DNS-End-
Resektion	 durchführen	 kann.	 Allerdings	 haben	 Daten	 aus	 einer	 Studie	 mit	 Xenopus-Eier	
Extrakten	 WRN	 als	 die	 wichtigste	 Helikase	 identifiziert,	 die	 in	 einem	 Komplex	 mit	 DNA2	
zusammenarbeitet,	 um	 die	 DNS-End-Prozessierung	 auszuführen.	 Daher	 wollten	 wir	
untersuchen,	 ob	 WRN	 und	 DNA2	 im	 Stande	 sind,	 zusammen	 die	 DNA-End-Resektion	 in	
menschlichen	Zellen	zu	verrichten.	 In	der	vorliegenden	Arbeit	 ist	gezeigt,	dass	WRN	 in	der	
Tat	 fähig	 ist,	 die	DNA2-abhängige	DNS-End-Resektion	 zu	 fördern,	 und	dass	 diese	Reaktion	
auf	 RPA	 und	 ATP	 angewiesen	 ist.	 Des	Weiteren	 findet	 dieser	 Prozess	 in	 5’	 zu	 3’-Richtung	
statt	 und	 generiert	 damit	 den	 erwarteten	 3’-Einzelstrang-DNS	 Überhang,	 der	 für	 die	 HR	
notwendig	 ist.	 Zusätzlich	 konnten	 wir	 zeigen,	 dass	 WRN	 und	 DNA2	 in	 vitro	 und	 in	 vivo	
miteinander	interagieren.	Ausserdem	haben	wir	herausgefunden,	dass	WRN	und	BLM	in	der	
Lage	 sind,	 die	 extensive	 DNS-End-Resektion,	 die	 durch	 DNA2	 ausgeführt	 wird,	 in	 vivo	 zu	
stimulieren.	 	 Schlussendlich	 haben	 wir	 demonstriert,	 dass	 BLM	 als	 Bestandteil	 des	 BLM-
TOPOIIIα-RMI1-RMI2	 (BTRR)	 Komplexes	 an	 der	 DNS-End-Prozessierung	 beteiligt	 ist.	
Zusammenfassung	
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Zusammenfassend	zeigen	unsere	Daten,	dass	DNA2	in	Zusammenarbeit	mit	WRN	oder	dem	
BTRR	Komplex	die	DNS-End-Resektion	in	menschlichen	Zellen	durchführt.	
Die	 DNS-End-Resektion	 generiert	 einen	 3’-Einzelstrang-DNS	 Überhang,	 der	
umgehend	von	RPA	ummantelt	wird	und	nicht	nur	als	Substrat	für	die	RAD51-Rekombinase	
dient,	 sondern	 auch	 als	 Plattform	 für	 die	Aktivierung	der	ATR-Kinase,	 die	 durch	ATRIP	 zur	
RPA-umhüllten	 Einzelstrang-DNS	 gebracht	 wird.	 Die	 aktivierte	 ATR-Kinase	 phosphoryliert	
CHK1	und	induziert	damit	einen	Kontrollmechanismus	für	DNS-Schäden,	der	umgehend	den	
Zellzyklus	 stoppt.	 Obwohl	 vorangehende	 Studien	 demonstriert	 haben,	 dass	 MutSβ,	 ein	
heterodimerisches	 Mismatch-Reparatur-Protein,	 bestehend	 aus	 MSH2	 und	 MSH3,	 im	 HR-
Mechanismus	 involviert	 ist,	 ist	seine	genaue	Funktion	nach	wie	vor	unklar.	 In	dieser	Arbeit	
wird	gezeigt,	dass	MutSβ	in	menschlichen	Zellen	als	Vermittler	in	der	ATR-Aktivierung	nach	
Formierung	 eines	 DNS-Doppelstranbruches	 dient.	 Wir	 beweisen	 ebenfalls	 die	
Proteinkomplexbildung	von		MSH2,	MSH3	und	ATR/ATRIP	in	menschlichen	Zellen.	Zusätzlich	
zeigen	wir,	dass	die	siRNS-gesteuerte	Elimination	von	MSH2	oder	MSH3	nach	der	Induktion	
eines	 Replikations-assoziierten	 DNS-Doppelstrangbruches	 die	 Phosphorylierung	 von	 ATR-
Zielproteinen	 und	 die	 Bildung	 von	 ATRIP-Fokuspunkten	 verhindert.	 Des	 Weiteren	 haben	
Mutationen	 in	 dem	 Mismatch-bindenden	 Teil	 von	 MSH3	 die	 Bindung	 von	 MutSβ	 zu	
bleibenden	Haarnadel-Strukturen	in	der	RPA-ummantelten	DNS	verunmöglicht	und	die	ATR-
Aktivierung	 in	 vivo	 eingeschränkt.	 Demzufolge	 zeigen	 unsere	 Resultate,	 dass	 MutSβ	 an	
beständige	 Haarnadel-Strukturen	 in	 RPA-umhüllter	 Einzelstrang-DNS	 bindet	 und	 die	
Rekrutierung	und	Aktivierung	des	ATR-ATRIP-Komplexes	vermittelt.		
Die	HR	hat	das	Potential	eine	Umgestaltung	der	chromosomalen	Struktur	durch	die	
Formierung	 sogenannter	 Crossover	 auszulösen.	 Während	 diese	 Crossover	 in	 meiotischen	
Zellen	für	die	Anordnung	der	einzelnen	Chromosomen	unerlässlich	ist,	durchläuft	die	HR	in	
mitotischen	 Zellen	 vorzugsweise	 den	 synthese-abhängigen	 Stang-Anlagerungs	 (SDSA)	
Mechanismus,	 der	 immer	 zu	 nicht-crossover	 Reparaturprodukten	 führt.	 Daraus	 lässt	 sich	
schliessen,	 dass	 mitotische	 Zellen	 ein	 sehr	 strenges	 Kontrollsystem	 für	 die	 Auswahl	 der	
einzelnen	 HR-Subreaktionen	 besitzen.	 Allerdings	 ist	 über	 den	 molekularen	 Mechanismus,	
der	 diesem	 System	 zugrunde	 liegt,	 nicht	 sehr	 viel	 bekannt.	 Hier	 ist	 gezeigt,	 dass	 in	
menschlichen	Zellen	die	siRNS-gesteuerte	Elimination	des	RECQ5-Proteins	die	Reparatur	von	
DNS-Doppelstrangbrüchen	 durch	 den	 SDSA-Weg	 vermindert.	 Die	 RAD52-vemittelte	 DNS-
Einzelstrang-Anlagerung	 ist	 ein	 fundamentaler	 Schritt	 des	 SDSA-Mechanismus,	 und	 wir	
Zusammenfassung	
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konnten	 beweisen,	 dass	 RECQ5	 dem	 inhibitorischen	 Effekt	 von	 RAD51	 auf	 diesen	 Prozess	
entgegenwirkt.	 Abschliessend	 demonstrieren	 wir,	 dass	 RECQ5	 den	 Austausch	 von	
Schwestrchromatid-Abschnitten	 verhindert	 und	 dadurch	 den	 BTRR	 Komplex	 ergänzt,	
welcher	 die	 Auflösung	 von	 HR-Zwischenprodukten	 katalysiert,	 um	 die	 Bildung	 von	
Crossovern	 zu	 vermindern.	 Unsere	 Resultate	 zeigen	 an,	 dass	 RECQ5	 während	 der	 post-
synaptischen	 Phase	 des	 SDSA-Mechanismus	 aktiv	 ist,	 um	 die	 Formierung	 von	 anomalen	
RAD51-Filamenten	auf	dem	neu	 synthetisierten,	 invasiven	DNS-Strang	 zu	unterbinden	und	
dadurch	einschränkt,	dass	die	Reparatur	den	riskanten	Crossover-Mechanismus	durchläuft.		
Zusammengefasst	 identifizieren	 die	 Resultate	 der	 vorliegenden	 PhD-Arbeit	 neue	
Schlüsselfaktoren	 und	 deren	 genaue	Wirkungsmechanismen	 in	 der	 zellulären	 Antwort	 auf	
DNS-Doppelstrangbrüche	und	stellen	daher	potentielle	therapeutische	Ziele	für	die	Therapie	
von	Krebsleiden	dar.	
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2. Summary		
Almost	 every	 cell	 of	 the	 human	 body	 is	 constantly	 exposed	 to	 DNA	 damaging	 agents	 of	
exogenous	 and	 endogenous	origin,	which	 can	 cause	 various	 lesions	 in	 the	 genome.	 These	
DNA	damages	can	have	mutagenic	potential	and	 lead	 to	genomic	 instability	 that	 is	one	of	
the	 major	 drivers	 of	 carcinogenesis.	 To	 deal	 with	 DNA	 alterations,	 cells	 have	 developed	
highly	specialized	DNA	repair	pathways.	Two	distinct	mechanisms,	termed	non-homologous	
end	 joining	 (NHEJ)	 and	 homologous	 recombination	 (HR),	 deal	with	 repair	 of	 DNA	 double-
strand	breaks	 (DSBs),	 the	most	dangerous	 form	of	DNA	damages.	HR	 is	an	accurate	 repair	
mechanism,	but	it	is	restricted	to	S	and	G2	phases	of	the	cell	cycle.	On	the	other	hand,	NHEJ	
can	take	place	throughout	the	cell	cycle	and	is	error-prone.	HR	reaction	relies	on	an	initial	5’	
to	3’	DNA	end	resection	step	generating	3’	ssDNA	overhangs.	In	yeast,	the	Exonuclease	1	and	
the	helicase/nuclease	Dna2	in	conjunction	with	the	RecQ-type	helicase	Sgs1	constitute	two	
independent	 pathways	 for	 long-range	 DNA-end	 resection.	 In	 human	 cells,	 there	 are	 five	
RecQ	 homologs	 known,	 namely	 RECQL1,	 BLM,	WRN,	 RECQL4	 and	 RECQL5.	 It	 has	 already	
been	 demonstrated	 that	 human	BLM	 can	mediate	DNA-end	 resection	 in	 conjunction	with	
DNA2.	However,	data	obtained	from	a	study	in	Xenopus	egg	extracts	identified	WRN	as	the	
major	helicase	that	works	in	complex	with	DNA2	to	catalyse	DNA-end	resection.	Therefore,	
we	wanted	to	investigate	whether	WRN	can	mediate	DNA-end	resection	in	conjunction	with	
DNA2	 in	 human	 cells.	 Within	 this	 thesis	 work	 it	 is	 demonstrated	 that	 indeed	 WRN	 can	
promote	 DNA2-mediated	 DNA	 end	 processing	 and	 that	 this	 process	 is	 dependent	 on	 the	
presence	of	RPA	and	ATP.	In	addition,	this	reaction	occurs	in	5’	to	3’	direction	generating	the	
anticipated	3’	ssDNA	overhang	required	for	HR	repair.	Further,	we	provide	evidence	for	the	
physical	 interaction	of	WRN	and	DNA2	 in	vitro	and	 in	vivo.	Moreover,	we	found	that	WRN	
and	BLM	stimulate	extensive	DNA	end	resection	by	DNA2	in	vivo.	Finally,	we	show	that	BLM	
mediates	 DNA-end	 resection	 as	 part	 of	 the	 BLM-TOPOIIIα-RMI1-RMI2	 (BTRR)	 complex.	
Taken	 together	our	data	provide	evidence	 that	 in	human	 cells,	DNA2	 resects	 broken	DNA	
ends	in	conjunction	with	either	WRN	or	BTRR	complex.	
	 The	3’	ssDNA	tail	generated	by	DNA-end	resection	 is	subsequently	coated	with	RPA	
and	 does	 not	 only	 serve	 as	 a	 substrate	 for	 the	 loading	 of	 RAD51	 recombinase,	 but	 also	
provides	a	platform	for	the	activation	of	ATR	kinase	that	 is	recruited	to	RPA-coated	ssDNA	
trough	 its	 interacting	protein	ATRIP.	Activated	ATR	phosphorylates	CHK1	 thereby	 inducing	
the	DNA	damage	checkpoint	that	leads	to	a	cell	cycle	stop.	Although	previous	studies	show	
Summary	
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that	 MutSβ,	 a	 heterodimeric	 mismatch	 repair	 protein	 composed	 of	 MSH2	 and	 MSH3,	 is	
involved	 in	 the	 HR	 process,	 its	 exact	 function	 is	 unclear.	 In	 this	 thesis	 work,	 it	 is	
demonstrated	that	MutSβ	serves	as	a	mediator	in	ATR	activation	upon	DNA	DSB	induction	in	
human	cells.	We	provide	evidence	that	MSH2,	MSH3	and	ATR/ATRIP	form	a	complex	in	cells.	
In	 addition,	 we	 show	 that	 siRNA-mediated	 depletion	 of	 MSH2	 or	 MSH3	 impairs	 the	
phosphorylation	of	ATR	targets	and	the	formation	of	ATRIP	foci	 in	response	to	replication-
associated	 DNA	 DSBs.	 Further,	 mutations	 in	 the	 mismatch-binding	 domain	 of	 MSH3	
diminished	 the	 binding	 of	 MutSβ	 to	 persistent	 hairpin	 loops	 in	 RPA-coated	 ssDNA	 and	
compromised	 ATR	 activation	 in	 vivo.	 Thus,	 our	 results	 demonstrate	 that	 MutSβ	 binds	 to	
hairpin	loop	structures	persisting	in	RPA-coated	ssDNA	at	sites	of	DNA	damage	and	mediates	
recruitment	of	the	ATR-ATRIP	complex	for	its	activation.	
	 HR	 has	 the	 potential	 to	 generate	 chromosomal	 rearrangements	 trough	 crossover	
formation.	 While	 crossovers	 are	 required	 in	 meiotic	 cells	 for	 proper	 chromosome	
segregation,	in	mitotic	cells,	HR	predominantly	proceeds	via	the	synthesis-dependent	strand	
annealing	 (SDSA)	 pathway	 that	 always	 leads	 to	 non-crossover	 products.	 This	 implies	 that	
mitotic	cells	possess	a	stringent	control	system	for	HR	subpathway	selection.	However	the	
underlying	molecular	mechanism	is	not	well	defined.	Here,	we	present	evidence	that	siRNA-
mediated	knockdown	of	RECQ5	impairs	DNA	DSB	repair	by	SDSA	in	human	cells.	Further,	we	
provide	 in	 vivo	 and	 in	 vitro	 data	 demonstrating	 that	 RECQ5	 helicase	 counteracts	 the	
inhibitory	effect	of	RAD51	on	RAD52-mediated	ssDNA	annealing,	a	key	step	of	SDSA.	Finally,	
we	 show	 that	 RECQ5	 suppresses	 sister	 chromatid	 exchanges	 in	 human	 cells	 in	 a	
complementary	 manner	 with	 the	 BTRR	 complex	 that	 mediates	 the	 dissolution	 of	
recombination	 intermediates	 to	prevent	crossovers.	These	results	suggest	 that	RECQ5	acts	
during	 the	post-synaptic	phase	of	SDSA	to	prevent	 formation	of	aberrant	RAD51	 filaments	
on	 the	 extended	 invading	 strand,	 thus	 limiting	 its	 channeling	 into	 potentially	 hazardous	
crossover	pathway.	
	 Taken	 together,	 the	 results	 of	 this	 thesis	 work	 identify	 new	 key	 players	 and	 their	
exact	working	mechanism	in	the	cellular	response	to	DNA	DSBs	and	thus	provide	potential	
new	therapeutic	targets	for	cancer	therapy.		
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3. Introduction		
	
The	 adult	 human	 body	 is	 composed	 of	 approximately	 1013	 cells	 that	 can	 be	 divided	 into	
several	different	cell	types	forming	highly	structured	tissues	and	organs	[1].	Despite	the	fact	
that	 many	 cells	 are	 highly	 differentiated	 and	 fulfil	 distinct	 functions,	 they	 all	 contain	 the	
same	genetic	 information	and	originate	from	one	single	progenitor	cell.	Cell	division	 is	not	
only	 a	 very	 important	 process	 during	 the	 development	 of	 a	 new	 individual,	 but	 it	 is	 also	
required	in	the	adult	organism.	Cells	with	a	short	lifespan,	for	instance	some	particular	white	
blood	cells,	need	to	be	renewed	in	order	to	maintain	proper	body	homeostasis	[2].	To	do	so,	
cells	undergo	the	so-called	mitotic	cell	division,	which	is	also	required	for	wound	closure	in	
case	of	 injuries.	Further,	meiosis,	which	 is	another	 type	of	cell	division,	 is	 fundamental	 for	
the	production	of	germ	cells.	Growth	and	division	of	cells	within	a	 tissue	 is	mediated	by	a	
variety	 of	 complex	 mechanisms	 involving	 intra-	 and	 extracellular	 signal	 transduction	
pathways.	Typically,	a	growth-	and	division-promoting	ligand	binds	to	a	cell	surface	receptor,	
for	 instance	 receptor-tyrosin	 kinases,	 triggering	 an	 intracellular	 response	 that	 leads	 to	 an	
increase	of	the	cell	size	and	activates	the	cell	division	cycle	[3].	In	healthy	tissues,	these	cell	
division-inducing	 signal	 molecules,	 also	 called	 mitogens,	 are	 highly	 regulated	 in	 their	
production	and	secretion	[3].	Thus,	cell	division	within	healthy	tissues	is	strictly	controlled.			
	 Cancer	 is	 a	 disease	 that	 is	 characterised	 by	 cells	 whose	 growth	 is	 out-of-control.	
More	 precisely,	 it	 is	 a	 group	 of	 diseases	 consisting	 of	 more	 than	 100	 different	 types	 of	
cancerous	maladies	 that	can	 in	principle	affect	every	organ	 in	 the	human	body.	The	single	
cancer	types	are	unique	with	their	own	causes,	symptoms	and,	if	available,	the	methods	of	
their	treatment.	The	body	is	harmed	when	aberrant	cells	start	to	divide	in	an	uncontrolled	
way	and	form	tumours,	which	can	grow	and	interfere	with	the	normal	function	of	organs.	In	
some	 cases,	 they	 even	 release	 hormones	 that	 can	 alter	 the	 function	 of	 the	 whole	 body.	
Tumours	should	not	be	seen	only	as	a	clump	of	cells	that	 is	proliferating	at	very	high	rate.	
They	 form	 complex	 tissues	 in	 conjunction	 with	 different	 non-neoplastic	 cell	 types.	 In	
extreme	cases,	like	the	Hodgkin's	lymphoma,	these	normal	cells	can	make	up	to	99%	of	the	
tumour	mass	[4].	Trough	heterotypic	interactions,	the	neoplastic	cells	communicate	with	the	
tumour-associated	stroma	cells	and	vice	versa	enabling	 the	 tumour	 to	also	actively	 recruit	
certain	cell	types	like	tumour-associated	macrophages.	Thus,	the	normal	cells	of	the	tumour	
stroma	are	not	only	important	for	the	survival	of	the	neoplasia,	but	also	actively	participate	
in	tumourigenesis	[3].	While	benign	tumours	are	located	to	a	defined	place	and	their	growth	
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is	 usually	 limited,	malignant	 cells	 start	 to	 invade	 the	 neighbouring	 healthy	 tissues.	 Under	
certain	 circumstances,	 cancer	 cells	 become	 able	 to	 move	 trough	 the	 blood	 and	 lymph	
system	and	form	malignant	tumours	that	spread	from	the	primary	tumour	to	other	locations	
in	the	body	to	form	metastases.	These	metastases	are	extremely	dangerous	and	cause	up	to	
90%	of	cancer	deaths	[5,	6].	Although	these	days	the	cardiovascular	diseases	are	the	leading	
causes	of	death,	cancer	might	 take	over	 this	position	 in	 the	near	 future	since	cancer	 is	an	
old-age	 disease	 and	 the	 expectancy	 of	 life	 is	 still	 increasing	 in	 industry	 nations	 [7,	 8].	 To	
understand	the	basic	principles	of	tumour	formation,	it	is	important	first	to	understand	the	
ongoing	processes	in	single	cells	that	can	lead	to	cancer	development.		
	 Hanahan	and	Weinberg	have	defined	 six	hallmarks	of	 cancer	 showing	 the	different	
capabilities	that	cells	may	have	to	acquire	during	their	evolution	from	normal	to	malignant	
tumour	cells	[9].	They	also	describe	that	development	of	cancerous	lesions	is	a	progressive	
process	 that	 passes	 trough	 several	 stages	 where	 these	 abilities	 are	 worked	 out	 [9].	 As	
already	mentioned	above,	cancer	cells	have	the	ability	to	proliferate	continuously,	which	is	
probably	 the	most	 fundamental	 hallmark	 in	 carcinogenesis	 (Figure	 1).	 They	 can	 do	 so	 by	
several	mechanisms.	One	possibility	is	that	cells	start	to	produce	mitogens	and	subsequently	
release	 them	 to	 stimulate	 their	 own	 surface	 receptors	 resulting	 in	 increased	 cell-division	
rates	 [10].	 Closely	 related	 to	 this	 action,	 the	 tumour-associated	 stroma	 cells	 can	 also	 be	
directly	 stimulated	 trough	heterotypic	 interactions	 to	 release	mitogens	 [11].	 Further,	 cells	
could	alter	signal	pathways	by	raising	the	expression	of	certain	receptor	proteins	or	simply	
by	enabling	receptor	kinases	to	transduce	signals	even	in	the	absence	of	the	corresponding	
ligand	[12].	Although	cell	proliferation	induction	and	maintenance	is	crucial	for	a	neoplasia	
to	grow,	 there	are	 tumour	suppressor	proteins	working	 in	anti-proliferative	programs	 that	
have	 to	be	overcome	(Figure	1).	Such	a	protein	 is	p53	 that	 is	a	central	effector	and	 found	
frequently	 inactivated	 in	 many	 cancer	 types	 [13].	 This	 protein	 gets	 input	 signals	 from	
intracellular	stress-	and	damage	response	machineries	and	decides	whether	the	progression	
of	the	cell	cycle	should	be	stopped	to	allow	repair	or	whether	apoptosis	should	be	induced	
[14].	 Apoptosis,	 the	 programmed	 cell	 death,	 is	 an	 important	 component	 of	 the	 cellular	
response	to	prevent	carcinogenesis	(Figure	1)	[15,	16].	There	are	two	major	pathways	known	
to	 induce	 apoptosis	 in	 a	 cell,	 an	 extrinsic	 and	 an	 intrinsic	 one	 [17].	 The	 extrinsic	 program	
relies	 on	 an	 extracellular	 death-inducing	 signal	 by	 for	 instance	 Fas-ligand	 binding	 to	 its	
receptor	 activating	 an	 intracellular	 signal	 cascade	 [17].	 On	 the	 other	 hand,	 the	 intrinsic	
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apoptotic	 system	 is	 dependent	 on	 intracellular	 signals	 that	 are	 transduced	 by	 p53	 for	
instance	[18].	Both	apoptosis	pathways	peak	in	the	activation	of	the	same	effector	caspases	
that	 lead	 to	 dismantling	 of	 the	 cell	 [17].	 Cancer	 cells	 have	 established	methods	 to	 avoid	
apoptosis	 by,	 among	 others,	 overexpressing	 anti-apoptotic	 factors	 of	 the	 Bcl-2	 family	 or	
altering	the	structure	of	the	aforementioned	Fas-receptors	in	a	way	that	its	ligand	is	unable	
to	bind	[19,	20].		
	 Having	established	ongoing	proliferation	in	the	progressive	development	of	a	cancer	
cell,	 it	will	encounter	the	 issue	that	most	cells	can	undergo	only	 limited	amount	of	growth	
and	division	cycles.	This	derives	from	the	end-replication	problem	in	which	telomeres	of	the	
chromosomes	in	the	cells	get	shorter	during	each	division	[21].	After	certain	numbers	of	cell-
doublings,	the	telomeres	get	to	short	and	the	cell	enters	a	phase,	called	senescence,	where	
it	 is	 still	 viable	 but	 does	 not	 divide	 anymore.	 Those	 cells	 that	 are	 able	 to	 bypass	 this	 first	
barrier	enter	the	crisis	phase,	a	second	arrest	phase	[22-24].	In	this	last	phase	usually	all	cells	
die	due	 to	 recurrent	 chromosome	bridge-breakage-fusion	cycles	 leading	 to	apoptosis	 [24].	
Nevertheless	 under	 some	 circumstances,	 they	 are	 able	 to	 escape	 and	 get	 unlimited	
replicative	 capability	 (Figure	 1)	 [3,	 22,	 23].	 This	 immortalization	 can	 be	 achieved	 by	 re-
expressing	telomerase,	an	enzyme	that	is	capable	of	re-extending	the	shortened	telomeres	
[24].	In	fact,	this	is	the	case	in	approximately	90%	of	malignant	tumours	[25].		
	 As	 in	 the	 case	 of	 normal	 tissues,	 tumours	 require	 nutrition	 and	 oxygen	 supply.	 In	
addition,	waste	products	accumulating	during	cell	metabolism,	like	carbon	dioxide,	need	to	
be	taken	away	from	the	cells.	Like	cell	division,	angiogenesis	 is	crucial	during	development	
and	tightly	regulated	in	the	adult	organism	where	it	is	only	activated	transiently	for	instance	
during	wound	healing	 [26].	 If	a	 tumour	expanded	up	 to	a	given	size,	hypoxia	and	nutrient	
starvation	induce	an	angiogenic	switch	(Figure	1)	[27].	This	mechanism	enables	tumour	cells	
to	 release	 factors	 like	 the	 vascular	 endothelial	 growth	 factor	 leading	 eventually	 to	
neovascularisation	of	the	tumour	tissue	[28].	In	contrast	to	the	highly	organised	network	of	
blood	 vessels	 in	 healthy	 tissues,	 tumour	 vasculature	 is	 unstructured,	 leaky	 and	 does	 not	
provide	 a	 continuous	 blood	 supply	 [29].	 This	 derives	 from	 the	 fact	 that	 angiogenesis	 in	 a	
tumour	 is	 constantly	 active	 and	 does	 not	 allow	 stabilization	 of	 the	 newly	 formed	 vessels	
[29].	
	 Probably	 the	 most	 devastating	 hallmark	 of	 cancer	 is	 the	 formation	 of	 metastases	
causing	 by	 far	 the	 most	 cancer-related	 deaths	 (Figure	 1)	 [5,	 6].	 Metastasis	 formation	 of	
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tumour	cells	is	a	multi-step	process	that	in	the	case	of	carcinomas	starts	with	the	invasion	of	
the	tissue	adjacent	to	the	primary	tumour	[30].	Malignant	cells	then	enter	the	vessels	of	the	
blood	 and	 lymphatic	 system	 by	 which	 they	 get	 transported	 throughout	 the	 body	 and	 at	
some	point	exit	the	vasculature	trough	a	process	called	extravasion	[30].	Next,	a	crucial	step	
is	 the	 survival	 of	 the	 mobile	 cell	 in	 a	 new	microenvironment	 at	 a	 distant	 location.	 Once	
adapted	 to	 the	new	conditions,	 the	migrated	 cell	 eventually	 grows	and	divides,	building	a	
new	 colony	 of	 neoplastic	 cells	 [30].	 To	 achieve	 this,	 cells	 need	 to	 undergo	 an	 epithelial-
mesenchymal-transition	by	which	they	loose	the	cell-cell	adhesion	and	become	migratory	[3,	
30-32].		
	
	
	
Figure	 1:	 The	 six	 hallmarks	 of	 cancer.	 Depicted	 are	 the	 capabilities	 that	 cells	 have	 to	 acquire	 to	 become	
malignant.	They	have	been	defined	by	Hanahan	and	Weinberg	in	2000	and	refined	in	2011.	Adapted	from	[3].	
	
The	above-described	hallmarks	of	cancer	cells	are	caused	by	genome	instability	and	tumour-
promoting	 inflammation	 [3].	 It	 is	 well	 known	 that	 macrophages	 infiltrate	 tumours	 where	
they	rather	induce	further	tumour	progression	than	fight	against	the	cancer	cells	[33,	34].	On	
the	 other	 hand,	 tumour	 formation	 and	 progression	 is	 also	 driven	 by	 specific	mutations	 in	
two	 key	 gene	 types	 called	 proto-oncogenes	 and	 tumour	 suppressor	 genes.	 A	 gain-of-
function	 mutation	 in	 proto-oncogenes	 turns	 them	 into	 oncogenes	 that	 enhance	 cell	
proliferation	 and	 inhibit	 differentiation	 and	 apoptosis	 [35].	 Conversely,	 a	 loss-of-function	
mutation	inactivates	tumour	suppressor	genes	that	usually	control	the	cell	cycle	and	induce	
apoptotic	pathways	to	prevent	cancer	formation	[35].	 	Next	to	the	mutations	 in	these	two	
kinds	of	genes	that	are	crucial	for	the	development	of	malignant	cells	an	unstable	genome	
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also	contributes	to	carcinogenesis.	There	are	different	types	of	genomic	instability.	Common	
among	 many	 cancers	 are	 altered	 number	 of	 chromosomes	 due	 to	 chromosome	
missegregation	during	mitosis	 [36-38].	 Further,	 structural	 anomalies	of	 the	DNA	can	occur	
trough	 deletions,	 insertions	 or	 translocations	 of	 chromosome	 parts.	 In	 addition,	 single	
nucleotides	can	be	changed,	lost	or	inserted	[39].	Thus,	a	very	important	objective	for	every	
cell	 is	 to	 propagate	 the	 genetic	 information	 to	 the	 next	 generation	 in	 an	 intact	 and	
unchanged	form.		
	
3.1. The	genome	maintenance	network		
Different	 sources	 of	 endogenous	 and	 exogenous	 origin	 can	 cause	 the	 above-mentioned	
types	 of	 genomic	 instability	 (Figure	 2).	 In	 fact,	 a	 single	 human	 cell	 can	 receive	 several	
thousands	 of	 DNA	 lesions	 every	 day	 [40].	 DNA	 damage	 can	 arise	 from	 physiological	
processes	that	take	place	during	the	cell	cycle.	Reactive	oxygen	species	(ROS),	formed	by	the	
respiratory	 chain	 of	 the	 cells,	 are	 such	 genotoxic	 chemicals	 that	 can	 harm	 the	 genetic	
information	(Figure	2).	ROS	release	by	macrophages	and	neutrophils	is	part	of	the	immune	
response	to	fight	pathogens,	demonstrating	the	toxic	characteristics	of	these	molecules	[41,	
42].	Further,	polymerases	can	 introduce	mismatches	while	 replicating	 the	genome	or	DNA	
strand	breaks	can	occur	if	DNA	topoisomerase	function	is	impaired	(Figure	2)	[43].	While	the	
phosphodiester	 backbone	 of	 the	 DNA	 is	 chemically	 extremely	 stable	 under	 physiological	
conditions,	hydrolytic	reactions	can	lead	to	deamination	of	bases	like	cytosine	or	cleavage	of	
the	glycosidic	bond	under	certain	conditions	resulting	in	DNA	lesions	[44-46].	
	 The	human	skin	is	constantly	exposed	to	ultraviolet	(UV)	light,	an	exogenous	source	
of	DNA	damage	(Figure	2).	Although	the	earth	is	covered	by	the	ozone	layer,	which	absorbs	a	
wide	spectrum	of	the	UV	light,	the	UV-A	and	UV-B	rays	passing	trough	this	protective	shell	
contain	 still	 sufficient	 amounts	 of	 energy	 to	 induce	 around	 105	 DNA	 alterations	 in	 every	
exposed	 cell	 per	hour	 [43].	 Ionizing	 radiation	 (IR),	 including	X-,	ϒ-,	α-,	 β-	 and	 cosmic-rays,	
also	harbours	mutation-inducing	potential	since	it	can	lead	to	DNA	lesions	like	DNA	double-
strand	breaks	(DSBs)	(Figure	2)	[47].	IR	is	generated	for	instance	by	the	radioactive	decay	of	
radionuclides	 or	 is	 used	 in	medical	 examinations	 while	 X-raying	 a	 patient.	 The	 danger	 to	
human	health	 that	emanates	 from	excessive	exposure	to	 IR	has	been	underlined	after	 the	
detonations	 of	 the	 atomic	 bombs	 in	 Hiroshima	 and	 Nagasaki	 in	 1945	 and	 by	 the	 nuclear	
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reactor	disaster	in	Chernobyl	on	the	26	April	1986.	Studies	done	with	workers	involved	in	the	
nuclear	power	plant	accidents	clean	up	in	Chernobyl	and	Fukushima	(11	March	2011)	show	
that	 structural	 chromosomal	 anomalies	 were	 present	 in	 cells	 of	 these	 people	 and	 lasted	
there	for	several	years	[48,	49].	
	 Exogenous	DNA	damaging	agents	 like	toxins	from	pathogens	or	heterocyclic	amines	
are	also	present	in	our	food.	Some	Aspergillus	species	like	A.	flavus	produce	extremely	toxic	
secondary	 metabolites	 called	 aflatoxins.	 Once	 they	 are	 metabolised	 in	 the	 liver,	 these	
mycotoxines	are	counted	to	the	most	carcinogenic	substances	[50,	51].	Depending	on	how	
the	molecules	are	processed,	they	form	epoxide	 intermediates	that	are	extremely	reactive	
or	are	converted	to	aflatoxin	M1	that	is	less	toxic	[51].	Epoxides	are	able	to	form	adducts	on	
DNA	 bases	 and	 are	 thus	 mutagenic.	 Consistent	 with	 their	 characteristics,	 it	 has	 been	
demonstrated	that	these	toxins	can	induce	the	formation	of	liver	cancer	[51-53].	
	 Some	 aromatic	 chemicals	 like	 ethidium	 bromide,	 which	 are	 frequently	 used	 in	
research,	 intercalate	 into	 double-stranded	 (ds)	 DNA	 leading	 to	 a	 deformation	 of	 the	 two	
strands	at	certain	spots.	Such	a	distortion	of	the	DNA	integrity	can	affect	DNA	replication	or	
transcription	and	is	therefore	thought	to	be	mutagenic	[54,	55].	Further,	metals	present	 in	
polluted	drinking	water	 like	arsenic	also	have	been	shown	to	 induce	DNA	damage	and	can	
lead	to	structural	anomalies	of	chomosomes	[56,	57].		
	 Particular	 genotoxic	 agents	 can	 also	 induce	 the	 formation	 of	 DNA	 single-strand	
breaks	(SSBs)	(Figure	2).	 If	this	DNA	lesion	is	 left	unrepaired,	the	replication	machinery	can	
collide	with	it	resulting	in	the	formation	of	DNA	DSBs.	Two	SSBs	that	are	located	closely	lead	
to	 the	 same	 effect.	 It	 is	 well	 known	 that	 DNA	 DSBs	 are	 highly	 cytotoxic	 and,	 if	 left	
unrepaired,	can	 lead	to	chromosomal	rearrangements	or	cell	death	[58,	59].	Nevertheless,	
DNA	DSBs	are	also	generated	on	purpose	in	V(D)J	recombination	of	maturating	B-	and	T-cells	
[60].	 In	 addition,	 the	 Spo11	 enzyme	 actively	 generates	 DNA	 DSBs	 during	 meiotic	
recombination	[61].	
	 To	 counteract	 DNA	 damage	 and	 the	 above-mentioned	 consequences	 that	 would	
come	along	with	 it,	cells	have	evolved	a	multiplicity	of	mechanisms,	collectively	 termed	as	
the	 DNA	 damage	 response	 (DDR)	 that	 recognises	 a	 DNA	 lesion,	 signals	 its	 presence	 and	
initiates	 sophisticated	 pathways	 resulting	 in	DNA	 repair	 (Figure	 2)	 [43,	 62].	Defects	 in	 the	
DDR	 machinery	 are	 usually	 linked	 to	 severe	 human	 diseases	 that	 are	 characterised	 by	
Introduction	
18	
predisposition	to	cancer	resulting	from	increased	sensitivity	to	certain	DNA	damaging	agents	
[43,	59,	63].		
		
Figure	2:	DNA	damaging	agents,	types	of	DNA	damage	and	corresponding	repair	pathways.	Different	agents	
cause	distinct	DNA	 lesions	 that	 have	 to	be	 repaired	by	 specialised	DNA	 repair	 pathways	 to	 restore	 genomic	
integrity.	 Abbreviations:	 cis-Pt,	 cisplatin;	 MMC,	 mitomycin	 C;	 (6–4)PP,	 6–4	 photoproduct;	 CPD,	 cyclobutane	
pyrimidine	dimer;	HR,	homologous	recombination;	EJ,	end	joining.	Adapted	and	modified	from	[63].		
3.2. DNA	repair	Pathways			
In	general,	each	type	of	damage	 is	 repaired	by	a	specialised	system	that	 restores	genomic	
integrity	trough	a	sequence	of	events	catalysed	by	different	proteins	[43,	63].	Mechanisms	
of	the	DNA	repair	pathways	that	deal	with	altered	bases	and	damaged	or	mis-incorporated	
nucleotides	as	well	as	one	of	the	repair	systems	that	deals	with	DNA	DSBs	will	be	discussed	
in	this	chapter.		
Introduction	
19	
3.2.1. Nucleotide	excision	repair		
	
DNA	helix-distorting	adducts,	 such	as	 those	generated	by	UV	 light	 (6-4	photoproducts	and	
pyrimidine	dimers),	are	eliminated	by	nucleotide	excision	repair	(NER)	that	is	split	 into	two	
sub-pathways:	transcription-coupled	NER	(TC-NER)	and	global	genome	NER	(GG-NER)	(Figure	
3)	 [64].	Both	pathways	are	mechanistically	akin,	however	 the	way	 in	which	 they	recognise	
the	 DNA	 lesion	 is	 different.	 While	 the	 GG-NER	 acts	 genome	 wide	 and	 checks	 for	 DNA	
distortions,	the	TC-NER	gets	activated	when	RNA-Polymerase	II	is	stuck	during	transcription	
because	of	 the	presence	of	DNA	damage.	 In	GG-NER,	 the	helix	distortion	 is	sensed	by	XPC	
binding	to	the	DNA	[65,	66].	Since	pyrimidine	dimers	cause	only	a	limited	destabilisation	of	
the	DNA,	initiation	of	the	pathway	is	assisted	by	XPE	and	DDB2	[67-70].	The	following	step	is	
the	 verification	 of	 the	 damage	 that	 is	 conducted	 by	 XPC-mediated	 binding	 of	 the	 TFIIH	
complex	 to	 the	 DNA	 [71].	 This	 transcription	 initiation	 and	 repair	 factor	 is	 composed	 of	
multiple	subunits	amongst	others,	the	XPB	and	XPD	helicases	[72].	These	proteins	are	able	to	
unwind	 the	 DNA	 around	 the	 lesion	 and	 have	 opposite	 polarities.	 However	 it	 has	 been	
demonstrated	 that	 rather	 the	 ATPase	 than	 the	 helicase	 activity	 of	 XPB	 is	 required	 for	
opening	 the	 DNA	 [73].	 The	 endonucleases	 XPF/ERCC1	 and	 XPG	 then	 cleave	 the	 damaged	
strand	5’	and	3’	 to	 the	damage,	 respectively,	 removing	a	stretch	of	22-30	nucleotides	 [74-
76].	RPA	binding	to	the	undamaged	strand	is	not	only	important	to	protect	it	from	damaging	
effects,	 but	 it	 is	 also	 required	 for	 positioning	 of	 the	 aforementioned	 nucleases	 [77].	
Restoration	of	DNA	 integrity	 is	 then	carried	out	by	combined	action	of	a	DNA	polymerase,	
PCNA,	RFC	and	a	DNA	Ligase	whereas	the	identity	of	the	proteins	depends	on	the	replicative	
state	of	the	cell	[75].		
	 TC-NER	mechanistically	overlaps	with	GG-NER,	however	the	initiation	of	the	pathway	
is	different	 (Figure	3)	 [75].	As	mentioned	above,	 if	RNA	Pol	 II	gets	stuck	on	a	 lesion	during	
transcription,	 recruitment	 of	 the	 CSA	 and	 CSB	 proteins	 leads	 to	 initiation	 of	 TC-NER	 [78].	
These	 proteins	 are	 crucial	 for	 the	 recruitment	 of	 other	 factors	 involved	 in	 TC-NER,	 the	
initiation	of	 the	repair	 reaction	and	potentially	also	 for	backtracking	of	 the	RNA	Pol	 II	 that	
would	otherwise	block	access	to	the	DNA	damage	[78,	79].	After	this	step,	TC-NER	proceeds	
with	the	recruitment	of	the	TFIIH	complex	and	all	the	subsequent	steps	described	above	for	
GG-NER	[75,	76].	
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Figure	 3:	 Nucleotide	 excision	 repair	 system.	 There	 are	 two	 nucleotide	 excision	 repair	 pathways	 known	 as	
transcription-coupled	nucleotide	excision	 repair	 (TC-NER)	 and	global	 genome	nucleotide	excision	 repair	 (GG-
NER).	Although	the	recognition	of	the	DNA	lesion	within	the	two	sub-pathways	is	mediated	by	different	factors,	
the	downstream	steps	are	identical.	GG-NER	is	initiated	by	helix-distortions	that	are	recognised	by	XPC.	In	case	
of	a	pyrimide	dimer	DNA	lesion,	the	XPE	and	DDB2	proteins	assist	in	this	first	step.	On	the	other	hand,	TC-NER	
is	started	by	a	stalled	RNA	Pol	II	that	recruits	CSA	and	CSB.	Verification	of	the	damage	is	then	conducted	by	the	
TFIIH	complex,	which	 is	composed	of	several	subunits.	Unwinding	of	 the	DNA	adjacent	to	the	damage	site	 is	
then	conducted	by	XPD	and	XPB	helicases,	creating	a	substrate	for	endonucleolytic	incision	by	XPF/ERCC1	and	
XPG	that	remove	a	22-30nt	oligonucleotide	containing	the	lesion.	The	ssDNA	generated	during	this	process	is	
protected	by	RPA	binding.	Eventually,	a	DNA	polymerase,	PCNA,	RFC	and	a	DNA	ligase	mediate	resynthesis	of	
the	DNA	to	fill	the	ssDNA	gap.	Adapted	and	modified	from	[80].	
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3.2.2. Mismatch	repair			
During	 replication	of	 the	 genome,	 errors	 can	occur	 in	 the	 form	of	 insertions,	 deletions	 or	
miss-incorporated	 nucleotides.	 Although	 the	 replicative	 polymerases	 δ	 and	 ε	 have	
proofreading	 function	 to	 check	 whether	 the	 inserted	 nucleotide	 is	 correct,	 it	 has	 been	
estimated	that	1	in	each	109	to	1010	base	pairs	is	mutated	per	cell	division	[81,	82].	To	detect	
and	 repair	 such	 mistakes,	 the	 mismatch	 repair	 (MMR)	 system	 continuously	 screens	 the	
newly	 synthesised	 strands	 [83].	 In	E.coli,	distinction	 between	 the	 template	 and	 the	 newly	
synthesised	strand	occurs	via	DNA	adenine	methylation	(Dam)	at	GATC	sites	[84].	Although	
the	MMR	mechanism	seems	to	be	evolutionarily	conserved,	it	is	currently	unknown	how	the	
strand	 discrimination	 in	 eukaryotes	 takes	 place	 [85].	 In	 addition,	 there	 are	 some	 other	
differences	 regarding	 the	 protein	 functions	 between	 bacteria	 and	 eukaryotes.	 MutS	 and	
MutL	 proteins,	 the	 core	 MMR	 factors,	 are	 present	 as	 homodimers	 in	 E.coli	 while	 in	
eukaryotic	 cells	 several	 heterodimeric	 complexes	 are	 formed	 by	 their	 homologues	 [85].	
MutSα,	 composed	 of	 MSH2	 and	 MSH6,	 binds	 to	 base-base	 mismatches	 and	 to	 small	
insertion-deletion	 loops	 (IDLs)	 of	 1-2	 nucleotides	 [86].	 On	 the	 other	 hand,	 MutSβ,	 a	
heterodimer	of	MSH2	and	MSH3,	recognises	IDLs	of	1-14nt	[87,	88].	Evidence	suggests	that	
MutSα	 as	well	 as	MutSβ	 are	 able	 to	 initiate	 repair	 of	 small	 IDLs	 [86].	 In	 addition	 to	 their	
mismatch-binding	domains,	both	protein	complexes	also	display	ATPase	activity	mediated	by	
Walker-type	 ATPase	 domains	 that	 are	 present	 in	 both	 subunits	 of	 MutSα	 and	 MutSβ,	
respectively	 [89].	 Among	 the	 other	 key	 players	 in	 the	MMR	 reactions	 in	 eukaryotic	 cells,	
there	 are	 three	 heterodimers:	 MutLα	 (MLH1/PMS2),	 MutLβ	 (MLH1/PMS1)	 and	 MutLγ	
(MLH1/MLH3)	[90].	Briefly,	the	model	for	eukaryotic	MMR,	especially	in	mammals,	involves	
the	 recognition	of	 a	mismatch	 in	 the	DNA	by	MutSα	or	MutSβ	 (Figure	4).	After	mismatch	
binding,	MutSα	 (MutSβ)	 is	 converted	 into	 a	 DNA	 sliding	 clamp	 that	 comes	 along	with	 an	
exchange	 of	 ADP	 to	 ATP	 in	 the	 ATP-binding	 pocket	 of	 the	 complex	 [91,	 92].	 Next,	MutLα	
associates	 with	 the	 sliding	 clamp	 and	 mediates	 endonucleolytic	 incision	 of	 the	 error-
containing	DNA	strand	[93].	Complete	removal	of	the	damaged	strand	is	then	carried	out	by	
Exonuclease	1	(EXO1)	[84].	Finally,	the	resulting	single-stranded	(ss)	DNA	gap	is	then	filled-in	
by	a	DNA	polymerase	such	as	Pol	δ	and	sealed	by	 ligase	 I	 [83].	 It	has	been	shown	in	yeast	
that	the	 incision	 in	case	of	a	mismatch	 in	the	 leading	strand	can	be	mediated	by	RNaseH2	
cleavage	 of	 mis-incorporated	 ribonucleotides,	 providing	 an	 entry	 side	 for	 EXO1-mediated	
strand	 degradation	 [89].	 The	 lagging	 strand	 has	 the	 advantage	 that	 synthesis	 in	 okazaki	
Introduction	
22	
fragments	provides	5’	ends	required	for	EXO1	function,	as	long	as	strand	maturation	is	not	
completed	and	does	therefore	not	necessarily	need	an	incision	for	MMR	to	proceed	[89].	In	
E.coli,	 the	 excision	 step	 is	 assisted	 by	 the	 UvrD	 helicase	 that	 unwinds	 the	 DNA	 until	 the	
mismatch	 is	 reached,	 the	 resulting	 ssDNA	 is	 then	 cleaved	 by	 an	 exonuclease	 (RecJ	 or	
Exo1)[94].	In	human	cells	the	identity	of	the	helicase	that	mediates	this	step	is	unknown,	but	
a	 recent	 study	suggests	 that	MCM9	performs	 the	DNA	unwinding	 reaction	 for	 subsequent	
degradation	by	EXO1	[95].	
	
Figure	4:	The	mismatch	repair	system.	Mismatch	recognition	in	mammalian	cells	is	mediated	by	either	MutSα	
(composed	of	MSH2	and	MSH6)	or	MutSβ	 (composed	of	MSH2	and	MSH3).	Depicted	here	 is	 repair	 initiation	
trough	MutSα	that	is	converted	into	a	sliding	clamp	upon	binding	to	a	mismatch.	In	the	next	step,	MutLα	gets	
recruited	and	performs	incision	of	the	error-containing	strand	providing	an	entry	site	for	EXO1.	After	excision	
of	the	error-containing	strand	by	EXO1,	a	DNA	polymerase	carries	out	DNA	resynthesis.	To	complete	the	repair	
pathway,	Ligase	I	restores	continuity	of	the	DNA	strand.	Adapted	and	modified	from	[96].	
	
3.2.3. Base	excision	repair			 	
If	oxidative	damage,	alkylation	agents,	deamination	or	depurination/depyrimidation	affects	
a	 single	base,	 the	base	excision	 repair	 (BER)	pathway	 is	 activated	 to	 replace	 the	damaged	
base	with	an	intact	one	(Figure	5)	[44,	97-100].	About	104	bases	in	every	cell	per	day	are	hit	
solely	 by	 spontaneous	 depurination	making	 BER	 important	 to	maintain	 genomic	 integrity,	
which	 is	underlined	by	 the	 fact	 that	 this	 repair	 system	 is	highly	conserved	between	E.	 coli	
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and	 mammals	 [101,	 102].	 Todays	 mechanistic	 model	 of	 BER	 divides	 it	 into	 two	 distinct	
pathways,	 the	 short	 and	 the	 long-patch	 BER	 [103]	 (Figure	 5).	 The	 first	 one	 results	 in	 the	
repair	 of	 a	 single	 nucleotide	 while	 the	 latter	 exchanges	 at	 least	 two	 nucleotides	 [97].	 To	
initiate	short-patch	BER,	a	specific	DNA	glycosylase	recognises	a	damaged	base	and	removes	
it	 by	 cleaving	 the	 N-glycosidic	 bond	 leaving	 behind	 an	 apurinic	 or	 apyrimidinic	 site	 (AP	
site)[97,	104].	Subsequently,	an	AP	endonuclease	1(APE1)	cuts	the	DNA	backbone	5’	of	the	
AP	 site	 [105].	 Then	 the	 polymerase	 β	 fills	 in	 the	 corresponding	 nucleotide	 [106,	 107].	
Ultimately,	 the	 sealing	of	 the	 remaining	nick	 is	 carried	out	by	DNA	Ligase	 III/XRCC1.	 Long-
patch	 BER	 has	 an	 identical	 initiation	 step	 like	 the	 short-patch	 repair,	 however	 after	 APE1	
cleavage,	Pol	δ	or	ε,	PCNA,	FEN1	and	ligase	I	are	recruited	to	the	damage	site	[97].	By	using	
its	strand	displacement	activity,	the	polymerase	inserts	new	nucleotides	and	generates	a	5’	
flap	that	requires	FEN1	cleavage	for	proper	repair	[108,	109].		
Extremely	similar	to	BER	is	the	pathway	of	DNA	SSB	repair,	however	the	recognition	
of	 the	 lesion	 is	 mediated	 by	 enzymes	 of	 the	 Poly(ADP-ribose)	 polymerase	 (PARP)	 family,	
primarily	PARP1	[110,	111].	
	
Figure	 5:	 Mechanism	 of	 base	 excision	 repair.	 One	 of	 several	 specialised	 DNA	 glycosylases	 cleaves	 the	 N-
glycosidic	bond	generating	an	AP-site.	Subsequently,	an	AP	endonuclease	(APE1)	cuts	the	DNA	backbone	5’	of	
the	AP	site.	The	resulting	gap	is	then	filled	with	a	new	nucleotide	by	polymerase	β.	In	the	final	step	the	Ligase	
III/XRCC1	complex	mediates	religation	of	the	DNA.	Although	the	long-patch	BER	has	an	identical	initiation	step,	
different	 factors	 are	 recruited	 after	 APE1	 cleavage	 to	 complete	 DNA	 repair.	 Trough	 its	 strand	 displacement	
activity	 Pol	 δ	 or	 ε	 resynthesizes	 the	 DNA	 producing	 a	 5’	 flap	 that	 is	 cleaved	 by	 FEN1/PCNA	 and	 genomic	
integrity	 is	 restored	 by	 Ligase	 I/PCNA.	 Abbreviations:	 BER,	 Base	 excision	 repair.	 Adapted	 and	modified	 from	
[112].	
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3.2.4. Non-homologous	end	joining		
The	 presence	 of	 a	 DNA	 DSB	 in	 genomic	 DNA	 is	 a	 very	 dangerous	 situation	 for	 a	 cell.	
Therefore	different	mechanisms	have	evolved	in	eukaryotic	cells	to	antagonize	these	lesions.	
Non-homologous	end-joining	(NHEJ),	being	one	of	these	mechanisms,	can	rapidly	repair	DNA	
DSBs	 (Figure	6)	 [113].	This	 repair	process	 is	 initiated	by	 the	Ku	heterodimer,	 composed	of	
Ku70	and	Ku80,	that	binds	to	the	DNA	ends	within	seconds	after	DNA	DSB	formation	[114].	
The	underlying	mechanism	for	this	 is	that	Ku	has	a	high	affinity	for	DNA	end,	 is	present	at	
high	concentrations	in	every	cell	and	further,	its	binding	to	DNA	does	not	rely	on	any	specific	
sequence	[115].	One	of	the	functions	of	the	Ku	heterodimer	is	protecting	the	DNA	ends	from	
being	 further	 processed.	 The	 protein	 forms	 a	 ring-shaped	 structure	 that	 can	 encircle	 the	
DNA	 ends	 and	 serves	 as	 a	 platform	 for	 recruitment	 of	 further	 core	NHEJ	 factors	 that	 are	
required	for	DNA	DSB	repair,	one	of	 them	being	the	DNA-dependent	protein	kinase	(DNA-
PK)	[115,	116].	DNA-PKcs,	which	is	the	catalytic	subunit	of	this	serine/threonine	kinase,	gets	
activated	upon	interaction	with	DNA-bound	Ku	complex	that	itself	slides	a	bit	further	on	the	
dsDNA	 [117-119].	 It	has	been	suggested	 that	Ku	 is	 important	 to	bridge	 the	 two	DNA	ends	
and	hold	them	in	close	proximity	to	each	other	[120].	This	process	potentially	also	involves	
other	factors	 like	DNA-PKcs	[115].	Next,	DNA	end	processing	may	be	required	since	a	DNA	
DSB	induced	by	distinct	DNA	damaging	agents	can	result	in	DNA	ends	that	are	not	ligatable.	
Such	 end-blocking	 obstacles	 are	 for	 instance	 chemical	 adducts	 or	 the	 absence	 of	 5’	
phosphate	 or	 3’	 hydroxyl	 groups	 at	 the	 DNA	 termini.	 Therefore,	 various	 proteins	may	 be	
required	 to	make	 the	ends	permissive	 for	 repair.	Not	only	nucleases	 like	Artemis,	WRN	or	
APLF,	 but	 also	 polymerases	 have	 been	 shown	 to	 act	 during	 this	 step	 of	 NHEJ	 [121,	 122].	
Finally,	 the	 DNA	 Ligase	 IV/XRCC4/XLF	 complex	 seals	 together	 the	 DNA	 ends	 to	 restore	
genomic	integrity.	In	this	reaction,	XRCC4	might	also	serve	as	a	scaffold	for	the	recruitment	
of	additional	NHEJ	proteins,	however	 it	also	stimulates	 the	Ligase	 IV	activity	 [115,	123].	 In	
addition,	 studies	 have	 revealed	 that	 XLF	 not	 only	 has	 a	 stimulatory	 effect	 on	 the	 Ligase	
IV/XRCC4	complex,	but	it	might	also	play	a	role	in	the	regulation	of	NHEJ	[124,	125].	Repair	
of	a	DNA	DSB	via	the	NHEJ	pathway	is	not	restricted	to	a	particular	cell	cycle	phase,	however	
it	 is	error-prone	because	of	the	end-processing	step	and	contributes	to	genomic	 instability	
trough	chromosomal	translocations	and	deletions	[126].	
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Figure	6:	Repair	of	DNA	double	strand	breaks	by	non-homologous	end	joining.	Rapid	binding	of	the	Ku70/80	
complex	 to	DNA	ends	of	a	DNA	DSB	 is	 followed	by	 recruitment	of	 the	DNA-dependent	protein	kinase	 to	 the	
damage	site.	The	next	step	includes	processing	of	the	DNA	ends	to	make	them	compatible	for	further	repair.	
Several	nucleases	and	DNA	polymerases	have	been	 shown	 to	act	at	 this	 step.	The	DNA	Ligase	 IV/XRCC4/XLF	
complex	then	mediates	religation	of	the	broken	DNA	end.	Abbreviations:	DNA	DSB,	DNA	double-strand	break.	
Adapted	and	modified	from	[127].		
There	 is	 another,	 but	 less	 well	 characterized,	 NHEJ	 pathway	 present	 in	 cells	 that	 is	 Ku-
independent.	 This	 pathway	 is	 termed	 alternative	 end-joining	 or	microhomology-mediated	
end-joining	 (MMEJ)	 and	 relies	 on	 the	 presence	 of	 5-25nt	 long	 homologous	 sequences	
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flanking	the	break	site	that	are	annealed	to	each	other	during	the	process,	and	therefore,	it	
always	results	in	a	deletion	[43,	128].		
	 To	maintain	 genomic	 stability,	 cells	 can	 counteract	 DNA	 DSBs	 via	 the	 homologous	
recombination	pathway	that	provides	faithful	repair.	This	mechanism	will	be	discussed	in	the	
next	chapter.	
	
3.3. Homologous	recombination			
Homologous	recombination	(HR)	is	a	critical	pathway	to	maintain	genomic	integrity	and	acts	
not	only	in	mitotic	cells,	but	also	during	meiosis	where	it	mediates	repair	of	DNA	DSBs	that	
are	 purposely	 generated	 by	 Spo11	 [61,	 126].	 HR	 is	 therefore	 involved	 in	 the	 crossover	
formation	during	meiosis	I	that	is	important	for	alignment	of	the	homologous	chromosomes	
and	 their	 subsequent	 segregation	 [129].	 In	 addition,	 this	 repair	 pathway	 is	 responsible	 to	
generate	genetic	diversity	[130].	Furthermore,	HR	also	plays	roles	in	recovery	of	stalled	and	
broken	 replication	 forks	 and,	 most	 importantly,	 in	 restoration	 of	 genomic	 integrity	 upon	
formation	of	DNA	DSBs	and	interstrand	crosslinks	[131].	In	contrast	to	end-joining	pathways,	
HR	provides	a	more	accurate	repair	mechanism,	however	this	goes	at	the	cost	of	flexibility.	
The	requirement	of	a	homologous	sequence	present	on	the	sister	chromatid,	restricts	HR	to	
S	and	G2	phases	of	the	cell	cycle	[43].		
	 First	knowledge	of	the	mechanism	of	HR	was	gained	from	studies	in	yeast.	Although	
there	are	 fewer	 factors	 involved	 in	yeast	HR	as	compared	to	HR	 in	higher	eukaryotes,	and	
the	 model	 has	 been	 updated	 during	 the	 past,	 the	 principle	 remains	 the	 same.	
Mechanistically,	HR	 can	 be	 divided	 into	 several	 steps:	 (i)	 nucleolytic	 resection	 of	 the	DNA	
DSB	 ends;	 (ii)	 formation	 of	 a	 nucleoprotein	 filament;	 (iii)	 homology	 search	 and	 strand	
invasion;	 (iv)	 DNA	 repair	 synthesis;	 and	 (v)	 resolution	 of	 recombination	 intermediates	 via	
different	sub-pathways	(Figure	7)	[131,	132].	
	 After	 initiation	 of	 HR	 by	 DNA	 damage	 like	 a	 DNA	 DSB,	 the	 DNA	 ends	 are	 first	
processed	 to	 generate	 3’	 ssDNA	 overhangs.	 From	 studies	 in	 yeast	 it	 is	 known	 that	 four	
nucleases	 participate	 in	 this	 first	 step:	 the	 Mre11-Rad50-Xrs2	 (MRX)	 complex	 [Mre11-
RAD50-NBS1	 (MRN)	 in	 humans],	 Exonuclease	 1	 (Exo1)	 (EXO1	 in	 humans),	 DNA	 replication	
helicase/nuclease	 2	 (Dna2)	 (DNA2	 in	 humans)	 and	 Sae2	 (CtIP	 in	 humans)	 (Figure	 7).	 The	
ssDNA	 generated	 in	 the	 DNA-end	 resection	 process	 is	 covered	 by	 the	 ssDNA-binding	
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replication	protein	A	 (RPA)	 [133,	134].	Binding	of	RPA	to	ssDNA	prevents	 the	 formation	of	
secondary	structures,	which	is	crucial	for	subsequent	loading	of	the	Rad51	recombinase	that	
performs	homology	search	and	strand	invasion	[135].	Although	RPA	is	extremely	important	
for	proper	formation	of	Rad51	filaments,	it	presents	a	kinetic	barrier	to	this	process	and	has	
to	 be	 removed	 prior	 to	 Rad51	 loading.	 Therefore,	 mediator	 proteins,	 divided	 into	 three	
different	 sub-classes,	 are	 assisting	 in	 this	 process	 to	 overcome	 this	 obstacle	 and	 assist	 in	
further	 downstream	 steps	 [130,	 136].	 The	 first	 class	 of	 these	 effectors	 in	 S.cerevisiae	
comprises	of	the	Rad51	paralogs	known	as	the	Rad55-Rad57	complex	and	heterodimers	of	
the	Shu	proteins	 (Shu1,	Shu2,	Psy3,	and	Csm2)	[130,	137].	 In	mammalian	cells,	 five	RAD51	
paralogues	 were	 identified	 so	 far,	 which	 form	 two	 distinct	 protein	 complexes	 (RAD51B-
RAD51C-RAD51D-XRCC2	 and	 RAD51C-XRCC3).	 Studies	 in	 yeast	 have	 shown	 that	 these	
proteins	 might	 be	 involved	 in	 the	 stabilisation	 of	 the	 nucleoprotein	 filament	 [138].	
Moreover,	 studies	 done	 in	C.	elegans	provided	 evidence	 that	 the	 Rad51	 paralogs	 actively	
contribute	to	Rad51	filament	remodelling,	thereby	promoting	strand	exchange	and	HR	[139].	
Rad52,	 represents	 the	 second	 class	 of	mediators	 that	 interacts	 physically	with	 Rad51	 and	
RPA	promoting	the	formation	of	a	Rad51	nucleoprotein	filament	[137].	The	third	mediator	
class	is	composed	of	the	human	BRCA2	protein	that	is	not	present	in	yeast.		BRCA2	interacts	
directly	with	RAD51	and	recruits	it	to	the	RPA-coated	ssDNA	at	the	DNA	DSB	site	[130,	140].		
	 In	the	next	step	of	HR,	the	Rad51-ssDNA-filament	performs	homology	search	on	an	
appropriate	 DNA	 template	 like	 the	 sister	 chromatid.	 Subsequent	 strand	 invasion	 is	 then	
completed	with	the	formation	of	a	displacement	loop	(D-loop)	(Figure	7).	Afterwards	distinct	
polymerases	 use	 the	 invading	 strand	 as	 a	 primer	 to	 start	 DNA	 synthesis.	 In	 humans	 it	 is	
known	that	also	translesion	polymerases	can	mediate	this	DNA	extension	step	in	addition	to	
the	replicative	polymerase	δ.	A	key	player	within	this	process	is	the	Rad54	motor	protein.	It	
stabilises	 the	 Rad51	 nucleoprotein	 filament	 and	 promotes	 D-loop	 formation.	 Eventually,	
Rad54	disrupts	the	Rad51	filament	to	allow	initiation	of	DNA	synthesis	[130,	131,	141,	142].	
	 To	complete	HR,	one	out	of	three	possible	sub-pathways	can	be	followed	(Figure	7).	
These	 are	 called:	 (i)	 break-induced	 replication	 (BIR);	 (ii)	 synthesis-dependent	 strand	
annealing	(SDSA);	and	(iii)	the	classical	DNA	DSB	repair	(DSBR).	The	latter	pathway	involves	
the	 formation	of	 a	 double	Holliday	 junction	 structure	 (dHJ)	 [130].	 BIR	 takes	 place	when	 a	
DNA	 DSB	 has	 only	 one	 accessible	 end	 as	 in	 the	 case	 of	 collapsed	 replication	 forks	 or	
unprotected	 telomeres	 [143].	 This	 repair	 pathway	 converts	 the	 D-loop	 into	 a	 replication	
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fork-like	 structure	 and	 DNA	 synthesis	 is	 then	 carried	 out	 until	 the	 chromosome	 end	 is	
reached,	 leading	to	a	restoration	of	the	genomic	 integrity.	However,	 loss-of-heterozygosity	
(LOH)	 and	 genomic	 duplications	 are	 potential	 outcomes	 of	 this	 reaction	 [143,	 144].	 If	 a	
second	 DNA	 end	 is	 present,	 somatic	 cells	majorly	 follow	 the	 SDSA	 pathway	 [145].	 In	 this	
reaction,	 the	D-loop	 is	 dismantled	 after	DNA	 synthesis	 and	 the	newly	 formed	DNA	 strand	
anneals	back	to	the	ssDNA-overhang	of	the	second	end	[130].	The	result	of	this	process	is	a	
non-crossover	product	that	limits	the	risk	of	genomic	rearrangements	[146].	A	dHJ	is	created	
when	the	second	end	of	the	DNA	DSB	is	captured	to	the	D-loop	(Figure	7).	Depending	on	the	
proteins	 involved	 in	 its	 processing,	 the	 result	 is	 either	 a	 non-crossover	 or	 a	 crossover	
outcome.	For	the	 latter,	 it	has	been	shown	that	 in	human	cells	the	SLX1-SLX4	and	MUS81-
EME1	 protein	 complexes	 and	 the	 Gen1	 resolvase	 are	 involved	 that	 all	 display	 distinct	
endonuclease	 activities	 [147-149].	 On	 the	 other	 hand,	 the	 Sgs1	 (BLM	 in	 humans)-DNA	
Topoisomerase	 3	 (Top3)-Rmi1	 (STR)	 complex	mediates	 the	 dissolution	 of	 dHJ	where	 non-
crossovers	are	produced	[130].	This	mechanism	involves	the	migration	of	the	two	junctions	
towards	each	other	and	a	final	cleavage	by	Top3	[130].	Another	homology-dependent	repair	
pathway	that	can	take	place	if	the	break	site	is	flanked	by	sequence	repeats	is	called	single-
strand	annealing	(SSA)	(Figure	7).	In	this	process,	the	initial	end	resection	step	is	followed	by	
the	 annealing	 of	 the	 repeat	 sequences.	 Finally,	 structure	 specific	 nucleases	 cleave	 off	 the	
incompatible	ssDNA	flaps	before	a	ligase	restores	DNA	strand	continuity.	SSA	always	results	
in	a	deletion	of	one	repeat	and	the	sequence	in	between	the	repeats.	Further,	SSA	does	not	
require	the	presence	of	a	template	DNA	to	perform	strand	invasion	to	proceed	with	repair	
and	 is	 therefore	not	 limited	 to	distinct	 cell	 cycle	phases.	 In	addition,	 since	Rad51	 filament	
formation	is	not	part	of	this	mechanism	it	is	Rad51	independent	[132,	137].	
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Figure	 7:	 Repair	 of	 DNA	 double-strand	 break	 by	 homologous	 recombination.	 The	 first	 step	 of	 HR	 is	 called	
DNA-end	 resection	 and	 leads	 to	 the	 generation	 of	 3’	 ssDNA	 overhangs	 that	 are	 then	 coated	 by	 RPA.	 Four	
nucleases	 are	 known	 to	 be	 involved	 in	 this	 process:	 the	Mre11-Rad50-Xrs2	 complex,	 Exo1,	 Dna2	 and	 Sae2.	
Mediator	 proteins	 like	 the	 Rad51	 paralogs	 or	 BRCA2	 then	 load	 the	 Rad51	 recombinase	 on	 the	 RPA-coated	
ssDNA,	 thereby	 removing	 RPA	 from	 the	 DNA,	 and	 stabilise	 the	 nucleoprotein	 filament	 that	 subsequently	
performs	homology	search	on	the	sister	chromatid	or	homologous	chromosome.	This	process	ends	up	 in	the	
generation	of	a	displacement	loop,	which	represents	a	branching	point	between	several	possible	downstream	
HR	sub-pathways	known	as	break-induced	replication,	synthesis-dependent	strand	annealing	and	the	classical	
DNA	DSB	 repair	 that	proceeds	 via	double	Holliday	 junction	 formation.	 Every	 sub-pathway	 leads	 to	a	 specific	
repair	product	with	crossover	or	non-crossover	outcome.	The	presence	of	 repeats	adjacent	 to	 the	break	site	
allows	 repair	 trough	 single-strand	 annealing	 pathway	 after	 extensive	 DNA-end	 resection.	 Proteins	 from	
S.cerevisiae	 and	 humans	 are	 written	 in	 blue	 and	 brown	 colour,	 respectively.	 Broken	 lines	 refer	 to	 newly	
synthesised	 DNA.	 Abbreviations:	 SSA,	 single-strand	 annealing;	 SDSA,	 synthesis-dependent	 strand	 annealing;	
BIR,	 break-induced	 replication;	 dHJ,	 double	 holliday	 junction;	 LOH,	 loss-of-heterozygosity.	 Adapted	 and	
modified	from	[130].	
	
3.3.1. DNA-end	resection	in	eukaryotes		
Processing	 of	 DNA	 ends	 after	 DSB	 formation	 is	 essential	 for	 HR	 to	 proceed.	 The	 5’	
terminated	 strands	 undergo	 nucleolytic	 degradation	 to	 form	 3’	 ssDNA	overhangs	 that	 are	
required	for	the	formation	of	Rad51	nucleoprotein	filaments.	From	studies	in	S.	cerevisiae,	it	
is	known	that	two	distinct	pathways	are	capable	of	mediating	rapid	and	extensive	resection	
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of	DNA	DSBs.	One	pathway	is	constituted	by	the	5’	to	3’	dsDNA	exonuclease	Exo1,	while	the	
other	is	composed	of	the	nuclease/helicase	Dna2	that	works	in	conjunction	with	the	3’	to	5’	
RecQ-type	helicase	Sgs1	[134,	150-156].	DNA-end	resection	is	a	two-step	process	where	the	
ends	 are	 first	 processed	 by	MRX	 in	 complex	with	 Sae2	 to	 generate	 a	 short	 ssDNA	 tail	 of	
about	 50-100nt	 [134].	 Next,	 one	 of	 the	 two	 above-mentioned	 pathways	 can	 take	 over	 to	
mediate	 long-range	 resection	 [134,	 155,	 156].	 However,	 the	 initiation	 step	 mediated	 by	
MRX/Sae2	seems	to	be	dispensable	for	extensive	5’	to	3’	strand	degradation	if	the	DSB	ends	
are	accessible	for	Exo1	or	Dna2/Sgs1	[155].	In	the	presence	of	end-blocking	obstacles,	Sae2	
has	been	shown	to	induce	a	latent	endonuclease	activity	of	MRX	that	specifically	incises	the	
5’	 terminated	 strand	downstream	of	 the	DNA	end,	 creating	 an	 entry	 site	 for	 Exo1	 and/or	
Dna2/Sgs1	[157].	
Several	 studies	 have	 shown	 that	 also	 RPA	 is	 crucial	 for	 DNA-end	 resection	 since	 it	
stimulates	 the	 unwinding	 activity	 of	 Sgs1	 [158].	 Further,	 RPA	 directs	 Dna2-mediated	
degradation	of	DNA	towards	the	5’	terminated	strand	and	protects	the	3’	strand	since	Dna2	
is	 only	 able	 to	 displace	 RPA	 from	 the	 5’	 strand	 [158-160].	 In	 addition,	 the	 Top3-Rmi1	
complex	 that	 is	 involved	 in	dHJ	dissolution	has	been	 shown	 to	have	 stimulatory	 effect	 on	
Sgs1/Dna2-mediated	 resection	 by	 enhancing	 the	 unwinding	 activity	 of	 Sgs1	 [158].	 Taken	
together,	 these	data	 suggest	 that	MRX/Sae2	display	a	 first,	 limited	end-processing	activity	
and	 recruit	 further	 downstream	 factors	 including	 Sgs1,	 Dna2,	 RPA,	 Top3	 and	 Rmi1	 that	
further	extend	the	3’	ssDNA	overhang.			
	 Comparison	of	the	resection	machineries	from	yeast	and	Xenopus	species	shows	that	
they	are	highly	conserved.	Consistent	with	this,	work	done	in	Xenopus	egg	extracts	showed	
that	 xDNA2	 is	 the	major	 nuclease	 involved	 in	DNA-end	 resection	 and	 depletion	 of	 xDNA2	
impairs	not	only	DNA	end	processing	but	also	DNA	DSB	repair	by	SSA	[161].	 In	addition,	 it	
has	been	demonstrated	that	the	homologue	of	the	human	Werner	syndrome	(WS)	protein	in	
Xenopus	(xWRN),	which	is	also	a	RecQ-type	helicase	like	the	yeast	Sgs1,	acts	in	concert	with	
xDNA2	 to	 promote	 extensive	 DNA-end	 resection	 [162,	 163].	 Related	 to	 yeast	 RPA,	 xRPA	
interacts	with	xWRN	directly	and	stimulates	its	helicase	activity	thereby	enhancing	the	DNA	
end	processing	reaction	mediated	by	xDNA2/xWRN	[164].	Although	the	MRN	complex	was	
able	to	stimulate	both	 long-range	resection	pathways,	which	 is	 in	 line	with	the	yeast	data,	
depletion	 of	 Mre11	 or	 CtIP	 (Sae2	 in	 yeast)	 in	 Xenopus	 egg	 extracts	 abolished	 DNA-end	
resection	almost	completely	[165].	Since	the	DNA	end	processing	machineries	 in	yeast	and	
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Xenopus	 are	 extremely	 related,	 it	 is	 highly	 likely	 that	 this	 system	 is	 conserved	 trough	
evolution	up	to	mammals.		
	 In	mammals,	the	RecQ	helicase	family	consists	of	five	members,	called	RECQL1,	BLM,	
WRN,	RECQL4	and	RECQL5	[121].	Although	it	is	well	known	that	BLM	participates	in	the	dHj-
dissolution	 pathway	 of	 HR	 and	 is	 able	 to	 unwind	 D-loops	 as	 well	 as	 G4-quandruplex	
structures,	it	has	been	observed	that	BLM	displays	a	rapid	localization	to	DNA-damage	sites,	
implying	that	it	plays	an	early	role	in	DDR	[166,	167].	In	line	with	this	observation,	a	recent	
study	has	shown	that	DNA2	and	BLM	form	a	complex	and,	in	the	presence	of	RPA,	are	able	
to	 mediate	 5’	 to	 3’	 DNA	 end	 processing,	 which	 is	 stimulated	 by	 addition	 of	MRN	 to	 the	
reaction	 [168].	 Interestingly,	also	nucleolytic	degradation	by	EXO1	could	be	augmented	by	
MRN,	RPA	and	BLM	[168].	Although	also	extensively	studied,	a	role	for	the	WRN	helicase	in	
DNA	DSB-end	processing	has	not	been	investigated	so	far.	Data	from	work	done	in	Xenopus	
egg	 extracts	 imply	 that	 WRN	 could	 also	 stimulate	 DNA2-mediated	 DNA-end	 resection	 in	
mammalian	cells.	Therefore,	one	of	the	goals	of	this	PhD	study	is	to	test	this	hypothesis.	
	
3.4. DNA-damage	signalling		
The	distinct	DNA	damage	repair	pathways	involve	action	of	a	huge	variety	of	proteins	whose	
activities	 have	 to	 be	 coordinated	 both	 spatially	 and	 temporally.	 Deregulated	 enzymatic	
activity	within	repair	processes	can	have	devastating	outcome	not	only	to	the	cell	itself	but	
also	to	the	whole	organism	in	case	of	cell	transformation	into	a	cancer	cell.	In	the	following	
section	 the	 signalling	 cascades	 of	 the	 DDR	 are	 discussed	 with	 a	 special	 focus	 on	 the	
processes	arising	upon	DNA	DSB	induction	in	mammalian	cells	to	promote	repair	trough	the	
HR	pathway.	
	 Two	key	players	of	the	DDR	machinery	are	called	ataxia	telangiectasia	mutated	(ATM)	
and	ataxia	telangiectasia	mutated	and	rad3-related	(ATR).	These	two	protein	kinases,	as	well	
as	DNA-PK,	belong	to	the	phosphatidylinositol	3-kinase	 like	protein	kinase	 (PIKK)	 family.	 In	
addition,	the	PARP	proteins,	of	which	17	are	known	in	humans,	are	also	crucial	for	the	DDR	
[169-171].	 Upon	 DNA	 DSB	 formation,	 PARP1	 and	 PARP2	 get	 activated	 and	 start	 the	
formation	of	poly(ADP-ribose)	(PAR)	chains	on	target	proteins.	These	PAR	chains	serve	as	a	
scaffold	to	recruit	other	factors	to	the	DNA-damage	site	[172].	One	of	these	proteins	is	the	
MRN	complex,	which	 is	known	to	 interact	with	PAR	molecules	via	 its	Mre11	subunit	[171].	
Association	of	MRN	with	DNA	DSBs	 leads	 to	 the	recruitment	and	subsequent	activation	of	
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ATM	(Figure	8)	[173,	174].	The	PIKK	kinases,	especially	ATM	in	this	case,	then	phosphorylate	
the	histone	variant	H2AX	at	serine	139	forming	γH2AX	that	is	widely	used	in	the	DDR	field	as	
marker	 of	 DNA	 damage	 [171,	 175].	 MDC1	 then	 binds	 γH2AX	 and	 mediates	 further	
recruitment	 of	 ATM	 resulting	 in	 an	 amplification	 of	 the	 γH2AX	 signal	 that	 can	 spread	
approximately	1-2	megabases	from	the	DNA	DSB	site	[171].	Activated	MDC1	then	mediates	
an	 exchange	 from	 a	 phosphorylation	 to	 an	 ubiquitination	 signal	 cascade	 by	 recruiting	 the	
ubiquitin	ligases	RNF8	and	RNF168	[176].	Linking	ubiquitin	moieties	to	target	proteins	leads	
to	 the	 recruitment	of	RAP80	that	 interacts	with	BRCA1	 [171].	Although	the	BRCA1	protein	
has	been	shown	to	be	involved	in	promoting	HR	the	underlying	mechanisms	remain	elusive.	
It	has	been	demonstrated,	that	BRCA1	can	associate	with	CtIP	in	S	and	G2	phases	of	the	cell	
cycle	where	 it	may	play	 a	 role	 in	 activation	 of	 extensive	 resection	 that	 is	 required	 for	HR	
[177].	However,	HR	can	only	repair	DNA	DSBs	if	a	template	sequence	is	present.	It	has	been	
shown	 that	 53BP1,	 which	 also	 gets	 recruited	 to	 these	 damage	 sites	 by	 the	 described	
signalling	cascade,	 inhibits	resection	and	promotes	NHEJ	under	certain	circumstances	[178,	
179].		
	 In	 addition	 to	 its	 role	 in	 the	 recruitment	 of	 repair	 factors,	 ATM	 also	 induces	 the	
activation	of	a	DNA	damage	checkpoint	trough	CHK2,	a	serine/threonine	kinase	that	in	turn	
phosphorylates	p53	in	response	to	DNA	DSB	formation	(Figure	8)	[180].	Activated	p53	acts	as	
a	transcription	factor	and	can	lead	to	cell	cycle	halt	to	provide	time	for	proper	DNA	repair	or	
if	this	is	not	successful,	it	can	induce	senescence	or	apoptosis	[181].			
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Figure	8:	DNA	double-strand	break	signalling	cascade.	PARP	protein	activation	upon	DNA	DSB	formation	leads	
to	association	of	repair	proteins	with	the	DNA	DSB	site.	First	proteins	recruited	to	DNA	DSB	sites	are	the	MRN	
complex	 and	 the	 ATM	 kinase.	 ATM	 phosphorylates	 the	 histone	 variant	 H2AX	 that	 is	 important	 for	 MDC1	
recruitment.	 In	 addition,	 it	 also	 activates	 the	 checkpoint	 kinase	 CHK2,	 leading	 to	 a	 cell	 cycle	 stop	 to	 allow	
restoration	of	 the	DNA	 integrity	or	apoptosis	 trough	p53.	MDC1	then	 recruits	 the	key	ubiquitin	 ligases	RNF8	
and	RNF168	 that	 finally	promote	 recruitment	of	 factors	 that	 initiate	homologous	 recombination	or	 the	non-
homologous	end	joining	pathway.	Adapted	and	modified	from	[171,	182].	
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The	activation	of	ATR	is	mediated	by	RPA-coated	ssDNA	that	is	generated	by	5’-3’	DNA-end	
resection	of	broken	DNA	ends	or	is	formed	at	stalled	replication	forks	(Figure	9)	[171].	ATR	is	
recruited	to	RPA-ssDNA	via	its	interacting	partner	ATRIP	[183].	At	the	same	time,	TOPBP1	is	
recruited	to	the	DNA-damage	site	by	the	RAD9-RAD1-HUS1	(9-1-1)	complex	that	is	loaded	on	
dsDNA	 at	 the	 ssDNA/dsDNA	 junction	 by	 the	 RAD17-RFC	 clamp	 loader	 [184,	 185].	 TOPBP1	
then	 activates	 ATR	 via	 direct	 interaction,	 which	 then	 leads	 to	 phosphorylation	 of	 the	
checkpoint	kinase	CHK1	[186-188].	Like	in	the	case	of	ATM,	also	this	signalling	cascade	can	
result	in	p53	activation	and	the	consequences	mentioned	above	[181].	In	addition	to	CHK1,	
ATR	phosphorylates	a	number	of	other	targets	 including	RPA	itself,	and	this	 is	required	for	
proper	DNA	repair	[189].	More	recently,	it	has	been	published	that	ATR	can	be	also	activated	
in	 a	 manner	 dependent	 on	 the	 MRN	 complex	 without	 the	 use	 of	 the	 9-1-1	 complex.	
Especially	the	interaction	between	NBS1	and	RPA	seems	to	be	crucial	for	this	MRN-mediated	
ATR	 activation	 [190].	 This	 suggests	 that	 there	 are	 several	 pathways	 involved	 in	 ATR	
activation	once	RPA-coated	ssDNA	has	been	formed.		
	 DNA	damage	recognition	and	signalling	 is	a	very	 important	process	 for	cells	and,	 in	
general,	specialised	proteins	carry	out	this	process.	Interestingly,	it	has	been	demonstrated	
that	some	factors	of	the	MMR	system	might	also	be	involved	in	DNA	DSB	repair	[191-194].	
MSH2	has	been	shown	to	be	 important	 for	efficient	HR-mediated	 repair	of	DNA	DSBs	and	
checkpoint	activation	[195-197].	In	addition,	a	recent	study	has	shown	that	MutSβ	seems	to	
be	important	for	DNA	DSB	repair,	since	cells	defective	for	either	subunit	of	this	MMR	protein	
display	 elevated	 levels	 of	 chromatid	 breaks	 [198].	 However,	 the	 exact	 role	 of	 MutSβ	 in	
response	 to	 DNA	 DSB	 remains	 elusive.	 Therefore	 another	 aim	 of	 this	 thesis	 was	 to	
investigate	the	underlying	mechanism	of	the	action	of	MutSβ	in	DNA	DSB	repair.	
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Figure	9:	ATR	activation	in	response	to	DNA	damage.	Association	of	ATR	with	RPA-coated	ssDNA	is	mediated	
by	ATRIP	 that	 directly	 interacts	with	RPA.	 In	 parallel,	 the	 RAD9-RAD1-HUS1	 complex	 recruits	 TOPBP1	 to	 the	
damage	site	 that	activates	ATR.	The	checkpoint	kinase	CHK1,	a	downstream	target	of	ATR,	 then	 induces	cell	
cycle	arrest.	Adapted	and	modified	from	[199].		
3.5. DNA	double-strand	break	repair	pathway	choice		
Cells	have	a	huge	arsenal	of	pathways	that	are	specialized	to	repair	certain	DNA	damage	but	
not	all	of	 them	might	be	suitable	at	a	given	scenario.	Therefore,	 the	selection	of	 the	most	
beneficial	 repair	mechanism	 is	 crucial	 and	depends	on	many	different	 factors	 like	 the	 cell	
type,	the	cell	cycle	phase	and	the	nature	of	DNA	damage	[130].	Although	the	presence	of	a	
homologous	sequence	during	S	and	G2	phases	of	the	cell	cycle	allows	DNA	DSB	repair	trough	
the	more	accurate	HR	pathway,	it	has	been	shown	that	during	this	cell	cycle	phases,	NHEJ	is	
still	the	predominant	DNA	DSBs	repair	pathway	[200].	This	might	be	due	to	the	fact	that	HR	
is	a	relatively	slow	process	that	takes	up	to	7h	to	be	completed,	while	genomic	integrity	can	
be	restored	by	NHEJ	in	around	30	minutes	[201].	In	addition,	HR	relies	on	tightly	controlled	
DNA-end	resection,	which	is	limited	in	G1	phase	of	the	cell	cycle	[202].	The	distinct	DNA	DSB	
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repair	 pathways	 have	 their	 own	 consequences	 to	 the	 genomic	 integrity.	 The	 deleterious	
MMEJ	and	SSA	mechanisms	and	BIR,	possibly	resulting	in	LOH,	have	mutagenic	potential	and	
are	therefore	likely	to	be	suppressed	if	other	systems	can	be	applied.	Therefore,	in	yeast	and	
mammalian	 cells,	 it	 has	 been	 shown	 that	 HR	 mainly	 proceeds	 trough	 SDSA	 pathway	 in	
mitotic	cells,	since	the	formation	of	dHJs	may	end	up	in	chromosomal	rearrangements	giving	
rise	 to	 genomic	 instability	 [203,	 204].	 In	 vitro	 studies	 demonstrated,	 that	 Rad51	 actively	
inhibits	 the	 formation	 of	 dHJs	 and	 therefore	 favours	 repair	 trough	 SDSA,	 but	 the	
mechanisms	underlying	the	regulation	of	HR	pathway	choice	are	still	not	very	well	defined	
[130,	 205].	 From	 studies	 in	 yeast,	 it	 is	 known	 that	 Mph1,	 a	 DNA	 helicase,	 counteracts	
formation	of	crossovers	[206].	Further,	another	helicase	called	Srs2	is	also	able	to	suppress	
crossover	products	[207].	In	mammalian	cells,	FBH1	displays	the	highest	sequence	homology	
to	 Srs2,	however	 its	 role	 in	 SDSA	 remains	elusive	 [208].	Other	 studies	have	demonstrated	
that	RECQ5	 is	able	 to	 interact	with	RAD51	and,	by	 translocating	along	 the	ssDNA,	disrupts	
the	RAD51-ssDNA	filament	[209-212].	Thus,	one	aim	of	this	study	was	to	define	a	potential	
role	for	RECQ5	in	the	regulation	of	HR	sub-pathway	choice.		
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4. Results	
4.1. Summary	of	the	results		
To	elucidate	the	role	of	WRN	in	DNA2-catalyzed	DNA-end	resection,	we	first	expressed	the	
recombinant	human	proteins	in	Sf-9	insect	cells	and	purified	them	to	apparent	homogeneity.	
By	using	a	biochemical	assay	based	on	a	linearised	pUC19	substrate,	we	found	that	WRN	in	
conjunction	 with	 DNA2	 can	 mediate	 5'-3'-directed	 DNA-end	 resection	 in	 a	 reaction	
dependent	on	RPA	and	ATP.	In	addition,	we	found	that	WRN	and	DNA2	interact	physically	in	
vitro	and	in	vivo	and	mapped	the	interaction	site	of	DNA2	on	WRN	by	using	GST-tagged	WRN	
fragments.	We	 then	 sought	 to	 define	 the	 roles	 of	 these	 proteins	 in	DNA-end	 resection	 in	
vivo.	Through	a	chromosomally-based	 reporter	assay	 for	DNA	DSB	repair	by	SSA,	we	were	
able	 to	 show	 that	 WRN	 and	 BLM	 act	 epistatically	 with	 DNA2	 to	 promote	 long-range	
resection	 of	 endonuclease-induced	DNA	DSBs	 in	 human	 cells.	 In	 addition,	we	 obtained	 in	
vitro	and	in	vivo	data	suggesting	that	BLM	promotes	DNA-end	resection	as	part	of	the	BLM-
TOPOIIIα-RMI1-RMI2	complex.	Taken	together	we	propose	a	model,	where	 in	DNA2/WRN,	
DNA2/BLM-TRR	 and	 EXO1	 constitute	 the	 resection	 machineries	 responsible	 for	 extensive	
DNA-end	resection	(Sturzenegger	et	al.,	JBC;	see	2.2.1.).	
	 Next,	we	identified	the	mismatch-binding	protein	MutSβ,	a	heterodimer	of	MSH2	and	
MSH3,	 as	 a	mediator	 in	 the	 process	 of	 ATR	 activation.	We	 showed	 that	MSH2	 and	MSH3	
form	a	complex	with	ATR	and	its	regulatory	partner	ATRIP,	and	their	depletion	compromises	
the	 formation	 of	 ATRIP	 foci	 and	 phosphorylation	 of	 ATR	 substrates	 in	 cells	 responding	 to	
replication-associated	 DNA	 DSBs.	 By	 using	 purified	MutSβ,	 we	 were	 able	 to	 show	 that	 it	
binds	 to	 hairpin	 loop	 structures	 persisting	 in	 RPA-ssDNA	 complexes	 and	 promotes	 ATRIP	
recruitment.	 Mutating	 the	 mismatch-binding	 domain	 of	 MSH3	 abolished	 the	 binding	 of	
MutSβ	 to	 DNA	 hairpin	 loops	 and	 its	 ability	 to	 promote	 ATR	 activation	 by	 ssDNA.	
Interestingly,	 in	 the	 presence	 of	 ATP/Mg2+,	 MutSβ	 dissociated	 from	 ssDNA	 and	 the	 ATR-
ATRIP	complex.	These	results	suggest	that	hairpin	loops	form	in	ssDNA	generated	at	sites	of	
DNA	 damage	 and	 trigger	 ATR	 activation	 in	 a	 process	mediated	 by	MutSβ	 (Burdova	 et	 al.,	
Mol.	Cell;	see	2.2.2.).	
	 By	using	a	chromosomally-based	reporter	assay,	we	demonstrate	that	RECQ5	is	able	
to	promote	DNA	DSB	repair	via	SDSA	pathway.	Surprisingly	we	found	that	FBH1	rather	seems	
to	have	an	 inhibitory	effect	on	 the	 SDSA	pathway.	Given	 the	possibility	 that	RECQ5	might	
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disrupt	abnormal	RAD51	filaments	that	are	formed	after	D-loop	unwinding,	we	sought	out	to	
test	this	hypothesis.	By	using	the	above-mentioned	SSA	reporter	assay,	we	could	show	that	
depletion	of	RAD51	or	its	loader	BRCA2	lead	to	an	increase	in	the	efficiency	of	SSA-mediated	
DNA	DSB	repair,	demonstrating	that	RAD51	filament	formation	suppresses	SSA.	In	line	with	
this	 observation,	 we	 showed	 that	 knockdown	 of	 RECQ5	 resulted	 in	 a	 decrease	 in	 SSA	
efficiency.	These	results	indicate	that	RECQ5	enhances	SSA	repair	by	removing	RAD51	from	
ssDNA.	 Using	 purified	 recombinant	 human	 proteins	 in	 an	 in	 vitro	 RAD52-mediated	 DNA	
annealing	 assay,	 we	 were	 able	 to	 gain	 insight	 into	 the	 molecular	 mechanism	 of	 RAD51-
ssDNA	 filament	 dynamics	 and	 could	 further	 strengthen	 our	 in	 vivo	 data.	 Next,	 we	 used	
chromatin	immunoprecipitation	(ChIP)	to	show	that	abundance	of	RAD51	near	a	given	DNA	
DSB	 site	 is	 augmented	 in	 RECQ5-deficient	 cells,	 indicating	 involvement	 of	 RECQ5	 in	
regulation	of	RAD51	 filament	 formation	at	DNA	DSBs.	 Furthermore,	we	 found	 that	RECQ5	
depletion	 in	cells	 lacking	BLM	 leads	 to	 increased	 frequency	of	 sister	 chromatid	exchanges,	
further	supporting	our	model	that	RECQ5	is	involved	in	promoting	SDSA	(Paliwal	et	al.,	NAR;	
See	2.2.3.).	
	 In	 collaboration	with	 the	 laboratory	of	Prof.	 Eli	Rothenberg,	we	could	demonstrate	
how	 BLM	 interacts	 with	 intra-strand	 G4	 structures.	 By	 applying	 single-molecule	 FRET	
technique,	we	were	able	to	show	that	the	activity	of	BLM	is	substrate	dependent,	and	highly	
regulated	by	 the	 length	of	 a	 short	 ssDNA	piece	 that	 separates	 the	G4	motif	 from	double-
stranded	DNA.	The	RQC	and	HRDC	domains	of	BLM	cooperate	during	binding	and	unfolding	
of	the	G4	structure,	where	the	RQC	domain	interaction	with	G4	is	stabilized	by	HRDC	binding	
to	the	short	ssDNA	strand.	It	is	also	demonstrated	in	this	study	that	the	G4	structure	forms	
an	obstacle	that	blocks	unwinding	of	downstream	dsDNA	that	could	be	resolved	by	addition	
of	BLM	and	ATP,	while	the	latter	is	only	required	for	translocation	of	the	helicase.	From	the	
results,	we	were	able	 to	present	a	model	 that	proposes	a	unique	role	 for	G4	structures	 in	
modulating	the	activity	of	DNA	processing	enzymes	(Chatterjee	et	al.,	Nat	Comm.;	See	2.3.1)
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4.2. Main	results	
4.2.1. DNA2	cooperates	with	the	WRN	and	BLM	RecQ	helicases	to	mediate	long-range	
DNA	end	resection	in	human	cells			
Andreas	Sturzenegger,	Kamila	Burdova,	Radhakrishnan	Kanagaraj,	Maryna	Levikova,	Cosimo	
Pinto,	Petr	Cejka	and	Pavel	Janscak	
	
	
This	article	was	published	in	the	Journal	of	Biological	Chemistry	in	2014.			
In	 this	 work,	 I	 purified	 recombinant	 human	 wild-type	 WRN,	 helicase-	 and	 nuclease-dead	
WRN	mutants,	 DNA2	 and	 BLM	 from	 Sf-9	 insect	 cells	 as	 well	 as	 RPA	 from	 E.	 coli.	 Next,	 I	
carried	 out	 all	 in	 vitro	 DNA-end	 resection	 and	 helicase	 assays.	 To	 demonstrate	 the	
interaction	between	WRN	and	DNA2,	 I	 performed	binding	 assays	with	 full-length	proteins	
and	GST-tagged	WRN	fragments.	 	 I	would	 like	 to	point	out	 that	a	part	of	 results	 shown	 in	
Figure	1	and	4	was	obtained	during	my	master	thesis	work.	
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4.2.2. The	Mismatch-Binding	Factor	MutSß	Can	Mediate	ATR	Activation	in	Response	to	
DNA	Double-Strand	Breaks			
Kamila	Burdova,	Boris	Mihaljevic,	Andreas	Sturzenegger,	Naga	Raja	Chappidi	and	Pavel	
Janscak			
This	work	was	published	in	Molecular	Cell	in	2015.			
Here,	 I	 first	 constructed	 different	 plasmids	 for	 expression	 of	 MSH3	 in	 human	 cells	
(pcDNA3.1-	 and	 pEGFP-c1-vector)	 and	 for	 generation	 of	 bacmids	 (pFastBac1-vector).	 In	
addition,	I	also	generated	various	MSH3	mutant	constructs,	where	the	loop-binding	motif	of	
MSH3	 has	 been	 mutated	 (MSH3-Y245S,	 MSH3-K246E	 and	 MSH3-Y245S/K246E).	 Next,	 I	
purified	 recombinant	MSH2/MSH3-Y245S/K246E	 herodimer	 after	 expression	 in	 Sf-9	 insect	
cells.	Moreover,	I	performed	all	DNase	I	footprinting	experiments.							
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4.2.3. Human	RECQ5	helicase	promotes	repair	of	DNA	double-strand	breaks	by	synthesis-
dependent	strand	annealing			
Shreya	Paliwal,	Radhakrishnan	Kanagaraj,	Andreas	Sturzenegger,	Kamila	Burdova	and	Pavel	
Janscak	
	
	
This	study	was	published	in	Nucleic	Acids	Research	in	2013.			
For	 this	 study	 I	 performed	 a	 number	 of	 SA-GFP	 and	 DR-GFP	 reporter	 experiments.	 To	
optimize	 the	 production	 and	 purification	 of	 RAD51	 wt	 and	 its	 K133R	 mutant	 version,	 I	
constructed	new	expression	vectors	based	on	the	pTXB3	plasmid	from	New	England	Biolabs	
and	 subsequently	 purified	 both	 proteins.	 Further,	 I	 conducted	 strand-annealing	 assays	 to	
show	that	wild-type	RAD51	also	displayed	a	similar	effect	like	the	RAD51-K133R	mutant	and	
to	 check	 whether	 WRN	 or	 FBH1	 could	 substitute	 for	 RECQ5	 in	 RAD51-ssDNA	 filament	
disruption.	Finally,	by	using	a	RAD51-interaction	deficient	mutant	of	RECQ5,	 I	 showed	that	
RECQ5-RAD51	interaction	is	required	for	RECQ5-mediated	disruption	of	RAD51	filaments.																										
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4.3. Results	from	collaborative	work			
4.3.1. Mechanistic	insight	into	the	interaction	of	BLM	helicase	with	intra-strand	G-
quadruplex	structures				
Sujoy	Chatterjee,	Jennifer	Zagelbaum,	Pavel	Savitsky,	Andreas	Sturzenegger,	Diana	Huttner,	
Pavel	Janscak,	Ian	D.	Hickson,	Opher	Gileadi	and	Eli	Rothenberg	
	
	
This	Study	was	published	in	Nature	communications	in	2014.			
For	 this	 work,	 I	 produced	 in	 E.	 coli	 and	 purified	 wild-type	 and	 helicase-dead	 BLM	 core	
fragments	(amino	acids	636-1298).																															
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5. Discussion		
In	this	thesis	work,	it	 is	demonstrated	that	WRN	and	BLM	can	promote	extensive	DNA-end	
resection	in	conjunction	with	DNA2	in	vitro	and	in	vivo.	We	show	that	WRN	directly	interacts	
with	DNA2	and	that	the	resection	of	broken	DNA	ends	by	these	proteins	is	dependent	on	the	
presence	of	RPA	and	ATP	and	occurs	with	a	5’	to	3’	polarity.	In	addition,	we	show	that	DNA-
end	 resection	 by	 WRN/DNA2	 or	 BLM/DNA2	 can	 take	 place	 effectively	 only	 if	 the	 DNA	
substrate	contains	a	short	3’	ssDNA	tail.	This	observation	is	 in	line	with	the	model	where	a	
first	resection	initiation	step	is	performed	by	MRN/CtIP,	generating	the	substrate	for	further	
long-range	resection	by	WRN/BLM	in	conjunction	with	DNA2	[134,	155,	213-215].		
The	involvement	of	WRN	in	DNA-end	resection	is	consistent	with	its	fast	localisation	
to	DNA	DSB	sites	[216].	In	addition,	WRN	directly	interacts	with	the	MRN	complex,	which	is	
one	 of	 the	 first	 proteins	 present	 at	 the	 break	 site	 and	 plays	 a	 crucial	 role	 in	 resection	
initiation	 [217].	 This	 might	 imply	 that	 MRN	 recruits	 WRN	 to	 sites	 of	 DNA	 DSBs	 to	 start	
extensive	resection.		
Our	 finding	 that	 the	 exonuclease	 domain	 of	WRN	 is	 dispensable	 for	 its	 function	 in	
DNA-end	 resection	 in	 conjunction	with	DNA2	 is	 consistent	with	 the	observation	 that	MRN	
stimulates	WRN’s	helicase	but	not	exonuclease	activity	 [217].	The	exonuclease	 function	of	
WRN	seems	 to	be	 rather	 involved	 in	other	processes	 like	 the	protection	of	 reversed	 forks	
upon	replication	stress	or	the	DNA-end	processing	during	NHEJ	 [218,	219].	Taken	together	
these	data	demonstrate	that	WRN	is	a	crucial	factor	in	the	repair	of	DNA	DSBs	and	that	the	
two	 functional	domains	of	 this	protein	mediate	distinct	 functions	 in	 this	 complex	process.	
	 Further	prove	that	WRN	is	a	key	player	in	preserving	genome	stability	is	provided	by	
phenotypes	of	patients	 suffering	 from	WS.	 This	disorder	 caused	by	 inherited	mutations	 in	
the	WRN	gene	is	characterized	by	premature	aging	and	cancer	predisposition	[220].	On	the	
cellular	 level,	 lack	 of	 WRN	 is	 manifested	 in	 extensive	 chromosomal	 deletions	 and	
translocations	[221-223].	However	it	should	be	noted	that	these	symptoms	are	likely	caused	
not	only	by	a	DNA-end	resection	defect	but	also	by	failure	of	several	other	processes	where	
WRN	 is	 involved.	 For	 instance,	 it	 has	 been	 shown	 that	 WRN	 participates	 in	 telomere	
maintenance	 where	 it	 interacts	 with	 telomeric	 proteins	 like	 TRF2	 and	 promotes	 strand	
exchange	[224,	225].	Further,	it	seems	that	WRN	is	also	engaged	in	DNA	replication	since	it	
has	been	shown	that	WS	cells	have	a	reduced	DNA	synthesis	rate	and	increased	frequency	of	
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replication	fork	stalling	[220].	These	observations	define	WRN	as	a	multifaceted	protein	that	
acts	in	various	processes	contributing	to	cell	homeostasis.		
In	 this	study	we	found	that	 like	yeast	Dna2,	also	the	human	ortholog	relies	on	 free	
ssDNA	 ends	 to	mediate	 an	 endo/exonucleolytic	 flap	 cleavage	 [152,	 226].	 In	 line	with	 this	
observation	recent	work	in	Xenopus	egg	extracts	revealed	that	DNA	DSB	break	ends	with	5’	
adducts,	which	 arise	 for	 instance	upon	 treatment	 of	 cells	with	 etoposide,	 are	 repaired	by	
xDNA2-mediated	resection	mechanism	but	only	after	removal	of	the	end-blocking	obstacle	
[227].	In	addition,	our	finding	that	the	presence	of	RPA	guides	DNA2	towards	degradation	of	
the	5’	terminated	strand	is	consistent	with	the	results	that	have	been	previously	published	
for	yeast,	Xenopus	and	mouse	Dna2	[135,	158-160].	These	findings	suggest	that	the	nuclease	
activity	of	Dna2	is	highly	conserved	trough	evolution.		
A	previous	study	has	provided	evidence	that	BLM	can	mediate	DNA-end	processing	in	
conjunction	with	DNA2	[168].	In	our	work,	we	found	that	although	the	helicase	activities	of	
WRN	and	BLM	were	similar,	WRN	promoted	DNA	resection	by	DNA2	more	efficiently	than	
BLM.	However,	the	BLM/DNA2-mediated	resection	reaction	could	be	stimulated	by	addition	
of	the	TRR	complex.	This	is	consistent	with	the	fact	that	during	dHJ	resolution,	BLM	acts	as	a	
part	of	the	BTRR	complex	where	TOPOIIIα	and	RMI1	stimulate	its	unwinding	activity	that	is	
the	driving	factor	of	the	DNA-resection	reaction	[228].	In	contrast	to	the	in	vitro	experiments	
where	 TRR	 stimulated	 the	 DNA	 end	 processing	 activity	 of	 BLM/DNA2	 only	 to	 a	 limited	
extent,	 depletion	 of	 RMI1	 from	 U2OS	 cells	 lead	 to	 a	 marked	 reduction	 in	 SSA	 repair	
efficiency.	 These	 data	 indicate	 that	 in	 vivo,	 RMI1	 is	 crucial	 for	 the	 DNA-end	 resection	
reaction	promoted	by	BLM/DNA2.	Consistent	with	this	observation,	it	has	been	shown	that	
RMI1	 and	 RMI2	 are	 important	 for	 the	 association	 of	 BLM	with	 DNA	 damage	 sites	 and	 its	
stability	[229,	230].	More	recently,	another	group	also	demonstrated	the	involvement	of	the	
BTRR	complex	in	DNA-end	resection	in	human	cells	[231].	
Surprisingly,	depletion	of	BLM	in	HEK293	cells	 increased	the	efficiency	of	SSA-repair	
events	 that	 are	 dependent	 on	 extensive	 resection,	 whereas	 in	 U2OS	 cells	 a	 marked	
reduction	 was	 noticed.	 In	 addition,	 we	 found	 that	 the	 concentration	 of	 BLM	 protein	 in	
HEK293	cells	was	much	higher	than	 in	U2OS	cells	 (data	not	shown).	 	Therefore,	 in	HEK293	
cells	where	BLM	exceeds	a	certain	threshold,	it	might	counteract	the	repair	of	DNA	DSB	via	
the	 SSA	 pathway	 possibly	 by	 unwinding	 the	 annealed	 complementary	 repeats.	 A	 similar	
repair	mechanism	that	also	relies	on	the	annealing	of	homologous	sequences	is	MMEJ.	BLM	
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has	been	shown	to	be	involved	in	regulation	of	this	pathway	to	prevent	its	deleterious	repair	
outcome,	which	supports	our	result	[232].	
Recently	is	has	been	shown	that	WRN/DNA2-mediated	end	resection	is	involved	not	
only	 in	processing	DNA	ends	after	DNA	DSBs,	but	also	 in	 resection	of	 reversed	 replication	
forks	to	allow	a	proper	replication	restart.	Interestingly,	BLM	seems	to	play	only	a	minor	role	
in	 this	mechanism	 demonstrating	 that	 the	 different	 resection	machineries	may	 also	 have	
distinct	functions	in	human	cells	[233].		
In	 addition	 to	 the	 investigation	 on	 how	RPA-coated	 ssDNA	 is	 generated	 at	 sites	 of	
DNA	DSBs,	we	also	asked	how	this	nucleoprotein	structure	activates	simultaneously	the	ATR	
signalling	 cascade.	 We	 identified	 the	 mismatch-binding	 protein	 MutSβ,	 a	 heterodimer	 of	
MSH2	 and	MSH3,	 as	 a	mediator	 of	 ATR	 activation.	We	 have	 found	 that	MSH2	 and	MSH3	
associate	with	 the	 ATR-ATRIP	 complex	 and	 are	 required	 for	 ATRIP	 foci	 formation	 and	 the	
phosphorylation	 of	 ATR	 targets	 in	 U2OS	 cells	 treated	with	 CPT,	 which	 induces	 DNA	 DSBs	
during	DNA	 replication.	Further,	we	have	obtained	evidence	 for	 the	persistence	of	hairpin	
loops	 in	RPA-coated	 ssDNA	 in	 vitro,	which	are	 recognised	by	MutSβ.	 To	demonstrate	 that	
MutSβ	specifically	associates	with	persisting	hairpin	 loop	structures	 in	ssDNA,	we	mutated	
the	 amino	 acids	 in	 MSH3	 that	 are	 responsible	 for	 mismatch	 binding.	We	 found	 that	 the	
interaction	of	MutSβ	mutant	with	hairpin	loops	was	completely	abrogated	in	vitro.	Further,	
we	 demonstrated	 that	 this	 MutSβ	 mutant	 failed	 to	 stimulate	 ATR	 activation	 in	 nuclear	
extracts	 supplemented	 with	 ssDNA	 and	 in	 human	 cells	 treated	 with	 CPT.	 These	 results	
demonstrate	that	binding	of	MutSβ	to	hairpin	loop	structures	persisting	in	ssDNA	is	essential	
to	 mediate	 ATR	 activation.	 Finally,	 we	 found	 that	 MutSβ	 dissociates	 from	 ssDNA	 hairpin	
loops	upon	addition	of	ATP	and	Mg2+.	
It	has	been	shown	previously	that	embryonic	fibroblasts	from	MSH2	knockout	mice	
displayed	a	 reduced	 survival	 rate	upon	DNA	damage	 induction	by	X-rays	 that	 induce	DNA	
DSBs	[196].	In	addition,	in	these	cells	the	checkpoint	kinase	CHK1	was	only	active	for	limited	
time	 and	 CHK2	 was	 not	 phosphorylated	 leading	 to	 improper	 G2/M	 checkpoint	 function	
[196].	Although	 it	has	been	demonstrated	 that	also	MutSα	 in	conjunction	with	MutLα	can	
activate	 ATR,	 this	 mechanism	 occurs	 in	 a	 resection	 independent	 manner	 [234,	 235].	
Consistent	with	these	results,	we	also	observed	an	impaired	phosphorylation	of	ATR	targets	
upon	MSH2	and	MSH3	but	not	MSH6	depletion	 in	 cells	 treated	with	CPT.	Taken	 together,	
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these	results	demonstrate	that	only	MutSβ,	but	not	MutSα,	can	assist	in	ATR	activation	after	
DNA	DSB	formation.	
In	 our	 proposed	 model,	 MutSβ	 binds	 to	 hairpin	 loops	 bringing	 the	 ATR-ATRIP	
complex	in	close	proximity	to	the	RPA-coated	ssDNA	formed	after	DNA	end	processing.	This	
would	allow	 subsequent	ATR	activation	by	TOPBP1	 that	 gets	 loaded	on	 the	 ssDNA/dsDNA	
junction	by	the	9-1-1	complex	[183,	186].	Interestingly,	work	done	in	yeast	showed	that	the	
9-1-1	checkpoint	clamp	is	able	to	promote	DNA-end	resection	by	Dna2	and	Exo1	[236].	If	this	
also	 holds	 true	 for	 mammalian	 cells,	 it	 suggests	 that	 DNA	 end	 processing	 is	 possibly	
enhanced	under	certain	circumstances	to	generate	the	substrate	for	MutSβ	binding	and	thus	
increased	ATR	activation.	
It	 has	 been	 published	 previously	 that	 ATR	 is	 important	 to	 prevent	 uncontrolled	
replication	origin	firing	and	protects	replication	forks	following	replication	stress	[237].	This	
mechanism	is	important	to	overcome	the	generation	of	loads	of	ssDNA	that	would	exhaust	
the	 cellular	 RPA	 pool	 [237].	 It	 is	 therefore	 possible	 that	 persisting	 hairpin	 loops	 in	 RPA-
coated	 ssDNA	 reflect	 a	 low	 amount	 of	 free	 RPA	 and	 thus	 lead	 to	MutSβ	 association	 and	
subsequent	enhanced	ATR	activation.	However	in	our	DNase	I	footpriting	assays,	we	found	
that	even	 in	 the	presence	of	 an	2-fold	excess	of	RPA	over	RPA	binding	 sites	 in	 the	 ssDNA	
substrate,	 hairpin	 structures	 were	 still	 present.	 This	 suggests	 that	 hairpin	 loops	 are	
potentially	also	 formed	within	RPA-coated	 ssDNA	under	normal	 conditions	 to	 form	MutSβ	
binding	sites.		
In	 our	 experiments,	 we	 found	 that	 MutSβ	 disassociates	 from	 hairpin	 loops	 upon	
addition	 of	 ATP.	 This	 is	 probably	 required	 to	 remove	 the	 protein	 from	 the	 DNA	 so	 that	
homology-directed	repair	can	proceed.	A	multi	step	process,	including	ATP	binding	by	MSH3,	
ADP-ATP	 exchange	 in	 MSH2	 and	 also	 ATP	 hydrolysis	 in	 MSH3,	 has	 been	 shown	 to	 be	
important	for	association	of	MutSβ	with	the	hairpin	 loop	substrate	and	potentially	also	for	
its	signalling	and	disassociation	within	MMR	[92,	238].	However	in	our	study,	the	addition	of	
ATP	as	well	as	its	non-hydrolysable	form	ATPγS	caused	the	release	of	MutSβ	from	the	hairpin	
loop.	This	indicates	that	there	might	be	a	distinct	mechanism	responsible	for	the	release	of	
MutSβ	from	hairpin	loops	in	ssDNA.			
Repair	of	DNA	DSBs	via	the	HR	pathway	can	proceed	trough	dHJ	formation	and	may	
end	up	with	chromosomal	rearrangements	due	to	crossover	formation.	However	in	mitotic	
cells,	SDSA,	which	always	results	in	non-crossover	products,	is	the	preferred	HR	mechanism	
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to	repair	DNA	DSBs	[145].	This	suggests	that	HR	subpathway-regulating	processes	are	active	
in	 proliferating	 cells	 that	 guide	 DNA	 DSB	 repair	 towards	 SDSA.	 In	 this	 thesis	 work,	 we	
demonstrate	that	lack	of	RECQ5	reduces	the	SDSA	repair	events	in	human	cells.	In	addition,	
we	provide	mechanistic	insight	into	how	RECQ5	regulates	HR	by	demonstrating	that	RECQ5	
counteracts	the	inhibitory	effect	of	RAD51	on	RAD52-mediated	ssDNA	annealing	in	vitro	and	
in	vivo.	Moreover,	we	provide	evidence	that	in	RECQ5-deficient	cells,	the	loading	of	RAD51	
at	 sites	 adjacent	 to	DNA	DSBs	 is	 increased	 as	 compared	 to	 normal	 cells.	 Finally,	we	 show	
RECQ5	and	BLM	act	 is	 a	 complementary	 fashion	 to	 suppress	 sister	 chromatid	exchange	 in	
cells.	 Together,	 our	 data	 suggest	 that	 RECQ5	 promotes	 the	 use	 of	 the	 SDSA	 pathway	 by	
inhibiting	the	formation	of	RAD51-ssDNA	filaments	after	D-loop	unwinding	and	is	therefore	a	
crucial	factor	involved	in	HR	regulation	in	human	cells.	
Our	data	are	supported	by	the	fact	that	cells	from	RECQ5-/-	mice	display	a	high	level	
of	 SCEs	 [212].	 In	 addition,	mice	 lacking	 RECQ5	 are	 prone	 to	 develop	 cancer	 [209].	 These	
malignancies	probably	arise	because	of	the	mutagenic	potential	of	crossover	events	that	are	
not	suppressed	anymore	by	RECQ5.	Consistent	with	this,	 it	has	been	shown	that	 in	human	
colorectal	 cancer	 cells,	 the	 RECQ5	mRNA	 level	 is	 markedly	 reduced	 compared	 to	 normal	
cells,	thereby	contributing	to	genomic	instability	[239].	
More	recently,	it	has	been	shown	that	RECQ5	is	involved	in	DNA	interstrand	crosslink	
(ICL)	repair	since	DT40	chicken	cells	where	RECQ5	was	knocked	out	displayed	an	increased	
sensitivity	to	ICL	inducing	agents	[240].	In	addition,	RAD51	foci	formed	after	treating		
RECQ5-/-	 cells	with	MMC,	which	 induces	 interstrand	crosslinks,	disappeared	slower	 than	 in	
wild	type	cells	demonstrating	that	RECQ5	plays	a	role	in	RAD51	filament	dynamics	[240].		
In	 collaboration	with	Prof.	 Eli	 Rothenberg’s	 lab,	we	proposed	 a	model	 for	 how	 the	
different	 BLM	 domains	 interact	 with	 the	 G4-quadruplex	 and	 lead	 to	 its	 unwinding	 to	
preserve	 the	 telomere	 structure.	 Such	 G4-elements	 can	 also	 be	 found	 adjacent	 to	
transcription	 start	 sites	 where	 they	 interfere	with	 transcription	 [241].	 A	 recent	 study	 has	
indeed	 demonstrated	 that	 in	 Bloom	 syndrome	 cells,	 mRNA	 expression	 levels	 of	 several	
genes	are	affected	by	the	presence	of	G4-quadruplexes,	indicating	that	BLM	also	plays	a	role	
in	gene	expression	regulation	by	unwinding	of	G4-structures	[242].	Interestingly,	it	has	been	
shown	recently	that	DNA2	is	able	to	cleave	DNA	with	G4-quadruplexes.	In	addition,	WRN	is	
also	able	to	unwind	G4-quadruplexes	[243].	Potentially,	 interplay	between	WRN	and	DNA2	
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or	BLM	and	DNA2	could	also	be	observed	at	sites	where	G4-structures	form,	which	can	be	
telomeres	but	also	promoter	regions	[244].	
	
5.1. Future	perspectives	
	
To	 fight	 cancer	 and	 to	 identify	 new	 cancer	 therapy	 targets,	 it	 is	 absolutely	 necessary	 to	
understand	the	underlying	processes	and	the	key	players	that	lead	to	cancer	development.	
In	 this	work,	we	 provided	mechanistic	 insight	 into	DNA-end	 resection	 in	mammalian	 cells	
and	defined	WRN	as	a	new	crucial	 factor	participating	 in	this	process.	DNA	end	processing	
mediated	by	EXO1	is	regulated	by	cyclin-dependent	kinase		(CDK)	1	and		CDK2	in	human	cells	
[245].	 In	addition,	ATM	also	seems	to	play	a	role	 in	this	process	since	 its	 inhibition	caused	
slower	 EXO1	 phosphorylation	 dynamics	 [246].	 On	 the	 other	 hand,	 there	 is	 only	 limited	
knowledge	about	the	regulation	of	DNA2-mediated	resection.	Yeast	Dna2	is	phosphorylated	
by	Cdk1	at	several	amino	acid	residues	located	in	the	N-terminal	region,	which	influences	its	
relocalization	to	DNA	DSBs	and	subsequent	nucleolytic	degradation	of	the	DNA	ends	[247].	
However,	human	DNA2	misses	this	domain	and	it	is	therefore	likely	that	other	mechanisms	
mediate	 its	 recruitment	 to	broken	DNA	ends.	A	protein	 that	 is	 potentially	 involved	 in	 this	
process	could	be	RPA	since	it	has	been	shown	that	RPA	is	indispensable	for	Dna2	association	
with	 DNA	 damage	 sites	 in	 yeast	 [135].	 In	 contrast,	 Exo1	 recruitment	 seems	 to	 be	 RPA-
independent	[135].	These	findings	further	 indicate	that	Dna2	and	Exo1	resection	pathways	
are	regulated	differently.	A	very	recent	study	identified	several	gene	products	in	yeast	that	
have	an	influence	on	Dna2	foci	formation,	either	positively	or	negatively,	upon	DNA-damage	
induction	 by	 phleomycin	 [248].	 In	 addition,	 work	 done	 in	 fission	 yeast	 defined	 Pxd1	 as	 a	
protein	that	 inhibits	the	association	of	Dna2	with	RPA-coated	ssDNA	and	therefore	inhibits	
resection	[249].	These	studies	suggest	that	there	might	be	additional	proteins	that	regulate	
DNA2	activity	in	human	cells.		
Controlling	 of	 the	DNA2-mediated	 resection	 pathway	 in	 human	 cells	 could	 also	 be	
mediated	 via	 its	 interacting	 RecQ	 helicases	 that	 are	 crucial	 for	 the	 degradation	 of	 the	 5’	
terminated	 strand	by	DNA2,	namely	WRN	and	BLM.	Consistent	with	 this	hypothesis	 it	has	
been	 shown	 that	 acetylation	 and	 deacetylation	 of	 WRN	 plays	 a	 role	 in	 coordinating	 the	
activity	 and	 localization	 of	 WRN	 during	 DNA	 repair	 [250,	 251].	 Further,	 also	 interaction	
partners	of	WRN	and	BLM,	for	instance	TRF1,	could	play	a	role	in	regulating	mechanisms.	In	
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line	with	this	theory,	it	has	been	demonstrated	that	phosphorylated	TRF1	stimulates	HR	and	
its	 depletion	diminished	ATR	 activation	 after	 treating	 cells	with	 IR	 [252].	Within	 the	 same	
study	evidence	is	provided	that	DNA-end	resection,	which	is	a	prerequisite	for	HR	and	also	
ATR	 activation,	 was	 abrogated	 upon	 knockdown	 of	 TRF1	 [252].	 Taken	 together,	 although	
some	 proteins	 are	 known	 to	 be	 involved	 in	 the	 regulating	 system	 underlying	 DNA-end	
resection	 in	 human	 cells,	 the	 interplay	 between	 these	 factors	 during	 the	 cell	 cycle	 are	
somewhat	poorly	understood	and	thus	require	further	investigation.	
BLM	and	WRN	are	not	only	 involved	in	DNA-end	resection	but	also	 in	several	other	
processes	within	 the	 cell	 and	 are	potential	 targets	 for	 cancer	 therapy.	 In	 fact,	 it	 is	 known	
that	 WRN	 protein	 expression	 is	 upregulated	 in	 certain	 leukemia	 cancer	 types	 [253].	
Potentially,	 this	 increase	 in	 WRN	 expression	 arises	 because	 the	 high	 replicative	 state	 of	
cancer	cells	generates	lesions	in	the	DNA	that	have	to	be	repaired.	Evidence	that	targeting	
WRN	in	cancer	therapy	could	be	effective	comes	from	a	study	dealing	with	head	and	neck	
squamous	 cell	 carcinomas	 where	 it	 has	 been	 demonstrated	 that	 siRNA-mediated	
downregulation	of	WRN	impaired	tumour	cell	growth	[254].		
Since	WRN	and	BLM	are	involved	in	the	elimination	of	G4-quadruplexes.	It	would	be	
interesting	 to	 check	 whether	 WRN	 also	 plays	 a	 similar	 role	 like	 BLM	 in	 unwinding	 G4-
structures	 in	 promoters	 to	 allow	 gene	 expression.	 In	 addition,	 since	 G4-quadruplexes	 can	
also	 form	 at	 telomeres,	 one	 could	 combine	WRN	 or	 BLM	 inhibition	 with	 a	 G4-stabilizing	
agent	like	telomestatin	to	enhance	the	effect	on	cancer	cells.	Given	that	WRN	is	involved	in	
many	processes	of	cell	homeostasis,	 it	 is	an	attractive	target	 for	cancer	 therapy	and	 it	has	
already	 been	 shown	 that	 inhibition	 of	 its	 helicase	 function	 could	 be	 used	 to	 treat	 certain	
malignancies	[255].		
Our	 study	 showing	 that	 the	 mismatch-binding	 factor	 MutSβ	 can	 mediate	 ATR	
activation	 brings	 progress	 in	 understanding	 the	 signalling	 mechanisms	 that	 are	 initiated	
upon	DNA	DSB	induction.	It	would	be	interesting	to	define	the	control	mechanisms	in	human	
cells	that	lead	to	association	of	MutSβ	with	hairpin	loops	formed	in	RPA-coated	ssDNA.	The	
histone	 deacetylase	 10	 has	 been	 shown	 to	 promote	MMR	 in	 HeLa	 cells	 by	 deacetylating	
MSH2	[256].	It	is	therefore	possible	that	acetylated	MSH2	within	MutSβ	prevents	binding	to	
the	DNA	substrate.	Thus,	 inhibiting	deacetylation	of	MSH2,	which	would	inhibit	as	well	the	
MMR	system,	could	be	an	effective	approach	for	cancer	therapy.	Such	an	inhibitor	could	also	
be	used	in	combined	medication	with	a	DNA	damaging	agent	that	induces	DNA	DSBs.	Since	
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cancer	cells	show	a	high	replication	rate,	it	is	likely	that	RPA	is	limited,	leading	to	uncovered	
ssDNA	that	would	usually	activate	the	ATR-CHK1	pathway	via	MutSβ	and	initiate	a	delay	in	
cell	 cycle	 progression.	 If	 this	mechanism	 is	 abolished,	 the	 checkpoint	 is	 not	 activated	 and	
hence	DNA	repair	is	affected	which	could	induce	lethal	effects	for	cancer	cells.		
The	 ATP-driven	 dissociation	 of	MutSβ	 from	RPA-coated	 ssDNA	 is	 likely	 to	 facilitate	
DNA	 repair.	 However,	 the	 molecular	 mechanism	 underlying	 the	 disassociation	 of	 MutSβ	
from	ssDNA	hairpin	loops	is	not	known.	To	further	explore	this	process,	mutant	versions	of	
MSH2	and	MSH3	in	their	ATPase	domains,	which	are	unable	to	bind	or	hydrolyse	ATP,	could	
be	generated.	These	mutants	 could	be	 tested	 for	 their	 ability	 to	bind	hairpin	 loops	within	
RPA-coated	ssDNA	to	define	the	exact	functions	of	ATP	binding	and	hydrolysis	by	MSH2	and	
MSH3	subunits	in	the	interaction	of	MutSβ	complex	with	ssDNA.		
In	 our	 study,	 we	 used	 CPT	 to	 induce	 replication-associated	 DNA	 DSBs.	 This	 drug	
treatment	caused	formation	of	numerous	DNA	DSBs	per	cell	generating	artificial	conditions	
where	 the	 amount	 of	 RPA	molecules	 is	 limited	 due	 to	 resection-dependent	 repair.	 Under	
such	 conditions,	 the	 formation	 of	 hairpin	 structures	within	 RPA-coated	 ssDNA	 could	 be	 a	
consequence	 of	 lack	 of	 RPA	 molecules	 leading	 to	 MutSβ-mediated	 ATR	 activation	 as	
described	 above.	 To	 test	 whether	 these	 hairpin	 structures	 do	 also	 persist	 under	 more	
physiological	 conditions,	 one	 could	 use	 cell	 lines	 carrying	 chromosomally-based	 DNA	 DSB	
repair	 reporters.	 Following	 induction	 of	 a	 single	 DNA	 DSB	 by	 expression	 of	 I-SceI	
endonuclease	in	these	cells,	association	of	MutSβ	around	the	DNA	DSB	site	could	be	studied	
by	ChIP.	
Work	on	RECQ5	described	in	this	thesis	has	demonstrated	that	it	is	able	to	guide	HR	
towards	 the	 SDSA	 pathway	 and	 thus	 is	 important	 to	 prevent	 the	 formation	 of	 potentially	
mutagenic	crossovers.	Although	HR	is	limited	to	S	and	G2	phases	of	the	cell	cycle	and	DNA-
end	resection	is	a	prerequisite	for	this	pathway,	it	has	been	shown	that	resection	also	occurs	
during	M	phase	 [257].	 Since	 the	 end	processing	mechanism	within	 this	 cell	 cycle	 phase	 is	
only	 dependent	 on	 MRN/CtIP,	 it	 is	 highly	 likely	 that	 it	 is	 not	 very	 extensive	 [257].	
Nevertheless,	 RAD51	 could	 be	 loaded	 and	 perform	 homology	 search	 that	 would	 lead	 to	
entangled	 chromosomes,	 which	 would	 interfere	 with	 chromosome	 segregation.	
Interestingly,	 it	 has	 been	 shown	 that	 Rad51	 binding	 to	 RPA-coated	 ssDNA	 in	 M-Phase	 is	
inhibited	 in	 a	manner	 dependent	 on	Cdk1	phosphorylation	 in	Xenopus	 egg	 extracts	 [257].	
This	 implicates	that	anti-recombinases	such	as	RECQ5	act	during	mitosis	to	prevent	RAD51	
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filament	 assembly	 in	 human	 cells.	 Interestingly	 data	 obtained	 in	 our	 lab	 by	 Jana	 Langhoff	
demonstrate	 that	 RECQ5	 is	 phosphorylated	 in	 early	 mitosis	 at	 serine	 727	 that	 is	 located	
adjacent	to	the	RAD51-interaction	domain	[210,	211].	As	serine	727	of	RECQ5	is	a	part	of	the	
CDK	consensus	site,	it	is	possible	that	in	M-phase,	CDK1-mediated	phosphorylation	of	RECQ5	
at	this	residue	can	stimulate	RECQ5’s	anti-recombinase	activity.	Thus,	it	would	be	interesting	
to	investigate	whether	RECQ5	also	plays	a	role	during	mitosis	to	prevent	initiation	of	HR.	
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7. Abbreviation	Index		
AP	site	 Apurinic	or	apyrimidinic	site	
APE1	 AP	endonuclease	
ATM	 Ataxia	telangiectasia	mutated	
ATR	 Ataxia	telangiectasia	mutated	and	rad3-related	
ATRIP	 ATR	interacting	protein	
BER	 Base	excision	repair	
BTRR	 BLM-TOPOIIIα-RMI1-RMI2	
BLM	 Bloom	syndrome	protein	
BIR	 Break-induced	replication	
ChIP	 Chromatin	immunoprecipitation	
Cis-Pt	 Cisplatin	
CDK	 Cyclin-dependent	kinase	
CPD	 Cyclobutane	pyrimidine	dimer	
D-loop	 Displacement	loop	
Dam	 DNA	adenine	methylation	
DDR	 DNA	damage	response	
DSBR	 DNA	DSB	repair	
DNA2	 DNA	replication	helicase/nuclease	2	
DNA-PK	 DNA-dependent	protein	kinase	
dHJ	 double	Holliday	junction	
DSB	 Double-strand	break	
ds	 double-stranded	
EJ	 End	joining	
EXO1	 Exonuclease	1	
GG-NER	 Global	genome	nucleotide	excision	repair	
HR	 Homologous	recombination	
IDL	 Insertion-deletion	loop	
ICL	 Interstrand	crosslink		
IR	 Ionizing	radiation	
LOH	 Loss-of-heterozygosity	
Abbreviation	index	
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MMEJ	 microhomology-mediated	end-joining	
MMR	 Mismatch	repair	
MMC	 Mitomycin	C	
MRN	 Mre11-Rad50-Nbs1	
MRX	 Mre11-Rad50-Xrs2	
NHEJ	 Non-homologous	end	joining	
NER	 Nucleotide	excision	repair	
Nt	 Nucleotides	
PIKK	 Phosphatidylinositol	3-kinase	like	protein	kinase	
PAR	 Poly(ADP-ribose)	
PARP	 Poly(ADP-ribose)	polymerase	
ROS	 Reactive	oxygen	species	
RPA	 Replication	protein	A	
STR	 Sgs1-Top3-Rmi1	
SSA	 Single-strand	annealing	
SSB	 Single-strand	break	
ss	 single-stranded	
SDSA	 Synthesis-dependent	strand	annealing	
TC-NER	 Transcription-coupled	nucleotide	excision	repair	
UV	 ultraviolet	
WS	 Werner	syndrome	
WRN	 Werner	syndrome	protein	
9-1-1	 RAD9-RAD1-HUS1	
(6-4)PP	 6-4	photoproduct	
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